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 In eukaryotes, a key way to regulate biochemical pathways and protein synthesis is through 
translation, the reading of an mRNA sequence to make proteins and enzymes.  In translation, one of 
the main steps that can be regulated is the formation of the initiation complex, which is necessary to 
position the machinery at the right spot on the mRNA before protein can be generated. A major 
player in translation initiation is the eIF4F complex (eukaryotic initiation factor 4F), made up of 
three different proteins: eIF4A, eIF4E and eIF4G.  The eIF4F complex specifically functions to 
recruit the small ribosomal unit, which serves as an interface between mRNA and the new protein 
being made, to the correct place on the existing mRNA strand.  In this way, eIF4F may control the 
rate of protein synthesis and, ultimately, the abundance, or conversely the absence, of specific 
proteins in organisms.  Therefore, the eIF4F complex may be useful in controlling expression 
systems, which can range in application from hormone production in animals to synthesizing useful 
medicines in plants.  
One of the major goals of the Browning lab is to understand better the effects of eukaryotic 
initiation factor mutants on phenotype in the Arabidopsis thaliana plant.  One part of the lab research 
thus focuses on the generation of “knock out” A. thaliana mutants, eliminating one or a combination 
of initiation factors.  Antibodies specific to the different initiation factors are useful for assaying 
protein expression and for immunolocalization, which allows you to visualize the presence or 
location of the protein which bind to that antibody.  While antibodies have been generated for 
several initiation factors already, some still remain elusive.  In a previous project, I produced 
antibodies to the Arabidopsis eIF4F complex and the lab already possesses Arabidopsis (At) eIF4E 
antibody.  However, antibodies specific to AteIF4G have not yet been made, due to difficulties 
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producing ample AteIF4G protein for antibody generation.  It is important to differentiate between 
Arabidopsis and wheat initiation factors, as the possessed wheat eIF4G antibody does not cross-react 
with AteIF4G.  A large part of the problem may be attributed to A. thaliana eIF4G protein instability 
compared to wheat eIF4G; the protein is prone to rapid degradation and low expression levels in E. 
coli.   
 In order to optimize the expression of AteIF4G, different vectors, expression systems, 
growth media, bacterial growth conditions and protein size were tried.  In testing different vectors 
and expression systems, I looked for more stable folding of the protein.  However, no large 
differences in expression were seen.  Different growth media were compared in protein expression 
levels, using media that slowed expression over a long amount of time and allowed for better folding 
and stabilizing of the protein, or media that provided excess amounts of nutrients to increase the 
output of all proteins, or media that simply followed basic protocols.  The slow-expression medum 
did not result in more final protein.  Conversely, the excess-nutrient medium resulted in an increase 
in eIF4G protein, but also an even larger amount of contaminant proteins that were not the desired 
eIF4G.  Compared to the basic media, there was not a significant increase in yield of pure eIF4G.  
Lastly, because the full-length eIF4G protein is approximately 150 kD, the excessive length of an 
already unstable protein could explain the surprisingly low protein expression level.  A cDNA for an 
N-terminal truncation of eIF tr4G (~ 24 kDa) was prepared.  This construct has a His-tag on the C-
terminus to simplify purification.  Antibodies raised to the N-terminal portion of eIF4G will 
presumably react with the full-length protein.  From this shortening of eIF4G, a noticeable increase 
in protein expression was observed.  From purified eIFtr4G protein, antibodies were produced in 
rabbits.  This eIF4G-specific antibody can be used in the future to determine the presence of eIF4G 
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1  Introduction 
 
One of the key processes in cell survival and functioning is the generation of 
proteins and enzymes, which are necessary for the cell in such important processes as DNA 
replication, cell division and recognition of substances and other cells.  This essential 
production of protein results from two processes that convert information encoded in the 
sequence of DNA to the amino acid sequence of proteins via an RNA intermediate.  The 
transfer of information from DNA to RNA occurs through transcription, while the reading 
of RNA to synthesize protein occurs via translation as shown in Figure 1.  In both 
transcription and translation, the process occurs in three phases: initiation, elongation and 
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Figure 1 .  General eukaryotic transcription and 
translation . Transcription converts information 
stored in DNA to RNA. Post-transcriptional 
modifications are made on the RNA, adding a 
poly(A) tail to the 3’ end and a methylguanosine
(m7Gppp) cap to the 5’ end. The resulting strand is 
called mRNA.  The mRNA is exported out of the 




1.1 The process of eukaryotic translation initiation 
 
Throughout this project, focus was placed specifically on the initiation phase of 
translation in eukaryotes.  In most eukaryotes, before the RNA transcript is exported from 
the nucleus to the cytoplasm of the cell, post-transcriptional modifications are made on the 
RNA, adding a cap to the 5’ end, the “front”, and a poly(A) tail on the 3’ end, the “back” 
(Figure 1).  These two components are vital for the efficient initiation of translation.  During 
cap-dependent translation initiation, the most common type in eukaryotic cells, a 
multiprotein complex is formed on the messenger RNA (mRNA) near the 5’ end.  This 
multiprotein complex, called the 43S pre-initiation complex, is formed through sequential 
recruitment of different eukaryotic initiation factors (eIFs) to the mRNA.  This pre-initiation 
complex serves to orient the translation reading machinery to the right place on the mRNA. 
One of the first steps in forming this pre-initiation complex is the recognition of the 
5’ cap of the mRNA transcript by eukaryotic initiation factor 4E (eIF4E), which binds 
eukaryotic initiation factor 4G (eIF4G) as seen in Figure 2a (Imataka 1997).  Second, eIF4G 
recruits eukaryotic initiation factor 4A (eIF4A) demonstrated in Figure 2b, which functions as 
an ATP-dependent RNA helicase (Von der Haar 2000).  Third, eIF4G binds to eIF4B, 
which binds poly(A) and stabilizes the binding of ATP to eIF4A, promoting the ATP-
dependent RNA helicase activity of eIF4A.  Also, poly(A)-binding protein (PABP), which 
also binds to the 3’ poly(A) tail as in Figure 2c (Kawaguchi 2002).  This assembly of proteins 
presumably circularizes the mRNA, through the simultaneous interaction of eIF4E, binding 
the 5’ end and both eIF4G and PABP bound to the 3’ end of the mRNA.  eIF4G also 
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associates with eukaryotic initiation factor 3 (eIF3), shown in Figure 2d, the ribosome-



















































































































Figure 2 . Eukaryotic translation initiation . (a) eIF4E 
binds the 5’ cap of mRNA.  eIF4G then associates with 
eiF4E. (b) eIF4A associates with eIF4G. (c) PABP 
binds the 3’ poly(A) tail as well as eIF4G, circularizing 
the mRNA, while eIF4B binds poly(A) and stabilizes 
eIF4A-ATP binding. (d) eIF3 binds to eIF4G, bringing 
the 40S ribosomal subunit. (e) eIF4A functions as an 
RNA helicase and unwinds 5’ folding. This creates the 
43S pre-initiation complex. (f) The pre-initiation 
complex scans for the first AUG in a 5’ -> 3’ direction. 
(g) The 60S unit is recruited to the complex.
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assembled pre-initiation complex so that translation can begin (Von der Haar 2000).  After 
the association of the mRNA and the 40S subunit, the eIF4A RNA helicase unwinds folding 
on the 5’ end of the mRNA that would otherwise impede the progression of the ribosome 
(Figure 2e).  Then, as shown in Figure 2f, the 43S pre-initiation complex scans towards the 3’ 
end of the transcript until it finds the correct translation start point (Kawaguchi 2002).  The 
final step in translation initiation is the association of the large subunit (60S) of the ribosome 
(Figure 2g), completing the ribosome complex and allowing the elongation phase of 
translation to begin.   
 
 
1.2  Translation initiation as a point of regulation 
 
Because of the necessity of proteins and enzymes for the basic functioning of cells 
and organisms, translation is a process that is heavily regulated.  The recruitment of the 40S 
ribosomal subunit to the mRNA is usually the rate-limiting step in protein synthesis, which 
makes translation initiation, more specifically the formation of the 43S pre-initiation 
complex, a logical point of translational regulation.  Translation initiation can control the 
abundance, or absence, of proteins and enzymes necessary to perform a certain function.   
Translational control has also been implicated in regulating gene expression (Han 
2002).  In other words, the amount of a gene transcript is not always proportional to the 
amount of protein that is synthesized because of the regulation of translation (Kawaguchi 
2002).  Because of the central role that the formation of the pre-initiation complex plays as 
the admission point of mRNA into translation, modulation of its formation can selectively 
promote the translation of certain mRNAs.  This can explain how a cell can be re-
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programmed to express genes in different levels in response to environmental or temporal 
signals (Morley 1997).  Studies have shown that in changing plants from light to dark 
environments, or exposing them to heat stress or water shortage, protein expression levels 
are changed for selected mRNAs (Kawaguchi 2002).  
 
1.3 The eIF4F complex 
 
The eIF4F complex is composed of eIF4E and eIF4G.  eIF4A and eIF4B, interact 
with this complex and are responsible for the binding of mRNA to the ribosome.  By 
convention, mammalian systems usually consider eIF4A as a part of the eIF4F complex, 
while in plant systems, the eIF4F complex is considered only eIF4E and eIF4G based on the 
ease of dissociation of eIF4A during extensive purification. 
 
1.3.1  eIF4E: the cap-binding component of eIF4F 
 
The cap-binding protein component, eIF4E specifically recognizes and binds the cap 
structure at the 5’ end of mRNAs, thought to be the first step in assembling the pre-
initiation complex (Ruud 1998).  The eIF4E directly interacts with eIF4G, and when it is 
within the eIF4F complex, eIF4E’s binding affinity for the 5’ cap increases about 10-fold.  It 
is hypothesized that the binding of eIF4G to eIF4E induces a conformational change, 
leading to a change in binding affinity (Prévôt 2003).  From these observations, it seems that 
although eIF4E alone can bind the cap structure, an eIF4E-eIF4G interaction, such as in the 
eIF4F complex, is needed for optimal binding of the cap (Prévôt 2003).  
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1.3.2 eIF4A: the RNA helicase of eIF4F 
 
 eIF4A is an ATP-dependent RNA helicase, meaning it harnesses energy from the 
hydrolysis of ATP to melt secondary structure and unwind RNA, facilitating ribosome 
binding and scanning for an AUG codon, or the starting point for translation.  In a similar 
change as in eIF4E, the rate of ATP hydrolysis and of RNA unwinding is greatly increased 
when eIF4A is part of the eIF4F complex (Ruud 1998).   
 
1.3.3 eIF4B: an RNA-binding protein 
 
eIF4B is an RNA-binding protein that bind the poly(A) tail and eIF4G, promoting 
the association of ATP with eIF4E (Kawaguchi 2002).  In this way, it promotes the ATP-
dependent RNA helicase activity of eIF4E to unwind the RNA strand.  eIF4B only 
promotes this activity when a part of the eIF4G/eIF4E/eIF4A protein complex, while not 
in the case of eIF(iso)4G/eIF(iso)4E/eIF4A complex (Kawaguchi 2002). 
 
1.3.4 eIF4G: the scaffold of eIF4F 
 
The common thread between all of the eIFs in the eIF4F complex, and most of the 
other eIFs involved in forming the 43S pre-initiation complex, is eIF4G.  eIF4G doesn’t act 
as a fixed docking station for the other eIFs, but is rather a changing scaffold that is 
modified by the proteins it associates with (Prévôt 2003).  Through all of these interactions, 
eIF4G acts as a molecular bridge between the 5’ cap structure and the 3’ poly(A) tail, and at 












Since most of the research I conducted was related to this important eIF4G protein, 
the majority of the remaining information presented will pertain to eIF4G: its characteristics, 
interactions, and applications.  The eIF4G protein can be divided into three domains: the N-
terminal region at one end, the middle region, and the C-terminal region at the other end 
(Figure 3).  The N-terminal region contains the eIF4E binding site and the PABP binding 
site.  The middle region of eIF4G contains the eIF4A and eIF3 binding sites.  The C-
terminal region contains a second eIF4A binding site and a docking site for Mnk1, a protein 
kinase that modulates the activity of mammalian eIF4E (Morino 2000).   
Not all of eIF4G is necessary to perform translation initiation, so to determine the 
part of eIF4G that was necessary, researchers replaced eIF4G’s N-terminal domain with an 
RNA binding protein, thus deleting the eIF4E and PABP binding sites (De Gregorio 1999).  
This allowed researchers to attach the still intact middle region to certain RNAs through the 
RNA binding protein.  By doing this, they could look at the ability or inability ability of 
different parts of eIF4G to initiate translation of a reporter mRNA, producing an easily 
 eIF4G protein regions
C terminusN terminus
PABP eIF4E eIF4A eIF3 eIF4A Mnk1
N-terminal domain Middle domain C-terminal domain
Figure 3. The domains of eIF4G . eIG4G is divided into three domains.  The N-terminal 
domain contains the PABP and eIF4E binding sites.  The middle domain contains binding 
sites for eIF4A and eIF3.  This middle domain has been determined as necessary for 
ribosomal recruitment.  The C-terminal region contains a second eIF4A binding site as well 
as a Mnk1 binding site.  This domain has been shown to play a modulatory role.
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detectable protein.  From this study, it became evident that the middle core region of eIF4G 
acts as the active “ribosome recruitment core” and is absolutely necessary for eIF4G to be 
translationally active (De Gregorio 1999).  In a different study, the C-terminal domain of 
mammalian eIF4G was shown to play a modulatory role.   
While in the De Gregorio study, the eIF4A binding site in the middle region was 
shown to be necessary for any translation initiation to occur, a second study shows that the 
second eIF4A binding site in the C-terminal region is necessary for vigorous translation.   
How the C-terminal region modulates eIF4G activity is still unknown, but two possible 
models have been proposed in which the C-terminal region changes conformation to allow 
eIF4A binding in two different ways (Morino 2000).  Both of these models exemplify how 
eIF4G is a dynamic molecule that continually changes shape to modulate initiation. 
Another essential function performed by eIF4G is the circularization of the mRNA, 
which occurs through the 5’ cap – eIF4E – eIF4G – PABP – 3’ poly(A) tail interactions 
(Figure 4).  Similar to the increases in efficiency of eIF4A and eIF4E when bound in complex 

























Figure 4. 5’-3’ 
circularization of 
mRNA.  This 
circularization serves two 
purposes: 1) it makes 
sure only intact mRNA’s 
will be translated and 2) 
it promotes efficient re-
initiation of translation 
because of the proximity 
of the ribosome subunits 
and the eIFs after 
dissociation.
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the 5’ cap about 40-fold, as well as the affinity of PABP for poly(A) tail (Borman 2002).  The 
significance of 5’ to 3’ bridging is that it may provide a proofreading mechanism so that only 
intact mRNAs, containing both the 5’ cap and the 3’ poly(A) tail, are translated (Craig 1998).  
Through this mechanism, translation of nonfunctional or damaged mRNAs would be 
prevented.  Secondly, the circularization of mRNA would promote more efficient re-
initiation of translation.  Because of the proximity of the ends, when ribosomes dissociate at 
the 3’ end of the mRNA after termination and eIF4F dissociates from the 5’ end after 
initiation, the ribosomes will be more readily recaptured to the eIF4F complex because they 
are close together, increasing the overall rate of translation (Borman 2002).   
 
1.4 Circularization of mRNA during initiation 
 
This circularization of mRNA has been shown in yeast and plants, with PABP 
binding the poly(A) tail, and in humans, with PAIP-1 playing this role (Craig 1998).  The 
importance of the 5’ – 3’ interaction can also be seen in the way that viruses have evolved to 
exploit this tactic to increase translation of viral proteins.  For example, the Barley yellow 
dwarf virus (BYDV) which does not have the 5’ or 3’ end modifications, and yet is still 
translated at a moderate level in plant hosts.  BYDV accomplishes this through binding host 
eIF4F to its own RNA.  After the eIF4F is recruited, the viral RNA interacts with itself to 
form a stem loop that essentially creates a “kissing-loop” that resembles the 5’ – 3’ 
circularization of the host (Kawaguchi 2002).   
Since the 5’ – 3’ interaction facilitates translation initiation, it follows that disruption 
of this interaction would inhibit translation on a global level.  Some mRNAs in plants have 
evolved a mechanism to deal with this.  For instance, heat shock in plants causes a general 
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decrease in translation because of the disruption of the 5’ to 3’ interaction.  However, the 
group of Heat shock proteins (HSP), which aid the plant in dealing with excessive heat, are 
still able to initiate translation efficiently because the HSP mRNAs establish a thermostable 
5’ – 3’ complex (Kawaguchi 2002).  Thus plants have evolved a way to use the 5’ – 3’ 
circularization to their advantage in making sure heat shock coping proteins are able to 
continue translation even under adverse conditions. 
 
1.5 Plant vs. general eukaryotic translation initiation 
 
My research focuses on plant-specific translation initiation.  In almost all aspects, 
plant translation is identical to general eukaryotic translation.  However, one difference is the 
presence of an alternate form, or isoform, of eIF4F, called eIF(iso)4F, in addition to eIF4F. 
Just as eIF4F contains eIF4E and eIF4G as its major components, eIF(iso)4F also contains 
their isozyme forms, eIF(iso)4E and eIF(iso)4G which differ in size and amino acid 
sequence.  The eIF(iso)4F complex has been found in all higher plants tested thus far 
including wheat, maize, cauliflower, Arabidopsis and barley(Browning 1996).  The eIF4G and 
eIF(iso)4G proteins show significant sequence homology, with the best conserved motif at 
the eIF4E binding site (Morley 1997).  Both the regular and iso- forms are present in higher 
plants.  The reason for this is still unclear, as they appear to have the same functional traits 
(Browning 1996).  eIF(iso)4F complex can substitute for the eIF4F complex in the absence 
of eIF4F, to recruit the 40S subunit to mRNA, and to unwind RNA when eIF4A is present.   
The few differences that have been noted include an eIF(iso)4E preference for 
hypermethylated caps and that eIF4F is more sensitive to 5’ secondary structure than 
eIF(iso)4F (Browning 1996).  Also, in wheat germ, eIF(iso)4F is present in 3- to 5-fold 
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higher amounts than eIF4F (Browning 1996).  Despite these distinguishing factors, plants in 
which eIF(iso)4E has been eliminated still show normal development under normal growth 
conditions, raising questions as to its purpose (Duprat 2002).   
 
 
1.6 Regulation of translation initiation through phosphorylation 
 
One of the ways to regulate translation initiation in mammalians is through the rate 
of formation of the eIF4F complex.  This can be modulated either through the 

















































Figure 5. Mammalian 
translation initiation regulation 
by phosphorylation. (a) When 
eIF4E is phosphorylated by 
Mnk1, it is inhibited from binding 
eIF4G, thus inhibiting translation 
initiation. (b) 4E-BP binds eiF4E 
at the same site that it usually 
binds eIF4G, thus inhibiting 
translation initiation.  However, 
when 4E-BP is phosphorylated, it 
is unable to bind eIF4E, thus 













The mammalian eIF4E protein can be phosphorylated by Mnk1, a protein kinase.  In its 
phosphorylated state, eIF4E does not bind well with eIF4G and also has a lower affinity for 
the 5’ cap thus decreasing translation initiation (Kawaguchi 2002).    
Another way to modulate eIF4E in mammals is through 4E-BP, which binds to 
eIF4E at the same site that it binds with eIF4G in its unphosphorylated state, thus inhibiting 
eIF4F formation shown in Figure 5b (Imataka 1997).  Conditions that promote growth, such 
as treatment of cells with insulin or growth factors, results in the phosphorylation of 4E-BP 
which leads to an increase in eIF4F complex formation, and a resulting increase in 
translation.  Another protein which regulates translation levels through interaction with the 
initiation complex in S. cerevisiae is Dcp1, a protein involved in the decapping process that 
marks mRNA for degradation.  Dcp1 is only able to act when bound to eIF4G when not 
bound to eIF4E.  In this way, eIF4G, depending on association with translation factors or 
decay proteins, can act as a sensor molecule to modulate the translation and degradation of 










Translation initiation proceeds as shown in Figure 2.
Figure 6. Potyvirus mechanism of taking over host translational machine ry . The viral genome is a single-
stranded RNA with a 3’ poly(A) tail but a capless 5’ end. They produce VPg, a protein which binds the 5’ end of 
the viral genome and acts as a cap mimic. VPg then recruits eIF4E and proceeds in translation initiation as 
shown in Figure 2.
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 New research has identified a novel disulfide bond in wheat eIF4E, which is also 
conserved in other plants.  The state of the Cys involved in the disulfide bond can be altered 
based on either a reducing or oxidizing environment (Mozingo 2007).  The redox state of a 
plant can be influenced by light or environmental stress and may regulate photosynthesis, 
seed development and germination (Mozingo 2007).  It is hypothesized that the redox state 
of the plant influences the formation of the disulfide bond, which then affects the binding 
affinity of eIF4E for the 5’ cap, eIF4G and other proteins and machinery that interact with 
eIF4E (Mozingo 2007). 
 
1.7 Viral and apoptotic strategies of taking over plant translational 
apparatus 
 
Studying plant virus infections and how they commandeer host translational 
machinery to translate their own genome provides a new take on translation initiation. This 
area of research is one example where more knowledge about translation initiation could 
help in treating and preventing viral infections.  The largest genus of plant viruses, Potyvirus, 
have a single stranded RNA genome, with a viral protein, VPg, bound to the 5’ end and a 3’ 
tail.  It is thought that VPg functions as a cap mimic and binds to eIF4E or eIF(iso)4E and is 
then able to recruit the rest of the initiation complex and translate its genome (Figure 6).   
Interestingly, once either eIF4E or eIF(iso)4E was mutated, plants developed 
resistance against several potyviruses after just a few amino acid changes in eIF(iso)4E.  This 
shows the necessity for eIF4E in plant viral infections and also implies that different 
potyviruses use different isoforms of eIF4E.  Similar results have been observed in other  
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studies involving viruses using eIF4G and/or eIF4E to hijack host translational machinery 
(Robaglia 2006).  Because viruses rely completely on host translational machinery to produce 
viral proteins, their ability to recruit translation initiation factors such as eIF4G is an 
important target for the control of viral diseases.   
Viruses have evolved many different, very effective mechanisms to take over host 
translation initiation machinery for their own viral genome translation.  One way in which 
some mammalian picornaviruses are able to do this is through internal initiation, rather than 
cap-dependent initiation, as there is no 5’ cap on the viral genome.  Internal initiation occurs 
in mRNAs that have a long 5’ untranslated region (UTR) with a special secondary structure 
that serves as an internal ribosome entry site (IRES) as shown in Figure 7a.  Infection with 
picornaviruses, such as poliovirus, is accompanied with an abrupt end of host protein 
synthesis, while virus translation continues.  This effect is largely mediated through 2A and L 
viral proteases, which cleave eIF4G, separating the binding sites for eIF4E and PABP (Figure 
7b).  By cleaving off the cap-binding component of eIF4G, the virus has inhibited cap-
dependent translation (Figure 7c), the usual method for host cell mRNAs, and made cap-
independent translation more likely, the method for viral RNA genome (Prévôt 2003).  Cap-
independent translation proceeds as the remaining C-terminal end of eIF4G binds to the 
IRES and continues to assemble the pre-initiation complex (Figure 7d).  Understanding all the 
varied ways that viruses are able to replicate so efficiently and steal resources from normal 
cell processes can contribute to developing new ways of controlling expression. 
The importance of eIF4G is further highlighted by its essential function in apoptosis, 
or programmed cell death in mammalian cells.  Apoptosis is a normal part of development, 


















phases, with the first being the induction phase, where signaling leads to the activation of 
death signaling proteins, and the second being the execution phase, in which there is rapid 
degradation and cell death.  One class of the death signaling proteins are the caspases: 
proteases that cleave the amino acid cysteine.  Because of the precedence of eIF4G as a 
target for the termination of host translation in viruses, it was estimated to be a likely target 
for caspases during apoptosis.  As theorized, caspase 3 is responsible for eIF4G cleavage and 
eIF4G cleavage corresponded to the extinction of translation (Marissen 1998).  By cleaving 
eIF4G, a crucial scaffolding protein in translation initiation, cell translation is shut off and 
disruption of cell processes ensues, explaining the quick execution phase of apoptosis.  
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Promote viral cap-independent translation
Initiation complex formed as 
in Figure 2b-g.
c
Figure 7. Viruses use host machinery for cap-indepe ndent translation initiation via an IRES . (a) eIF4G 
is cleaved by 2A and L proteases, separating the binding sites for eIF4E and PABP from the rest of the 
protein. A more detailed version of eIF4G can be seen in Figure 3. (b) The N-terminal domain of eIF4G binds 
with eIF4E in the host, but is unable to initiate translation without the rest of eIF4G. Thus, host cap-dependent 
translation is inhibited. (c) Viral genomic RNA does not contain a 5’ cap, but contains 5’ UTR folding, an IRES, 
that can be used to initiate translation with the middle and C-terminal regions of eIF4G.  Thus, viral cap-
independent translation is promoted.
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1.8 Current Work 
 
The Browning laboratory studies eukaryotic initiation of translation in plants, using 
Arabidopsis thaliana and wheat as model systems and is seeking a molecular description of the 
interaction of mRNA with initiation factors eIF4F, eIF4A and eIF4B.  The focus of my 
research is the expression of AteIF4G protein to use to raise rabbit antibodies.  Antibodies 
are a useful tool for the visualization and analysis.  Recombinant protein may be used to raise 
rabbit antibodies specific to that protein, which is used both in in vitro methods, such as 
Western analysis or immunoprecipitation, and in situ methods, such as immunolocalization.  
One of the research projects of the laboratory is to investigate the effects of knockouts of 
different combinations of eIFs in A. thaliana, looking at the resultant phenotypic changes, 
differences in development, and environmental responses.  When conducting these studies, 
antibodies specific to the knockout initiation factor of interest are very useful in confirming 
the absence of gene products and in monitoring eIF levels in response to different 
conditions.  Because there have been difficulties in the past with expressing sufficient full 
length AteIF4G for antibody production, I created a shorter version of the protein, 
AteIFtr4G.  The vector that houses the gene is a possible reason for low expression, because 
when eIF4G was originally cloned into its vector, pET22b, the vector had to be modified, 
creating vector XpET22b.  This modification could have damaged the vector to operate at a 
less than optimal level, resulting in lower protein expression.  Therefore, we will be inserting 
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the eIFtr4G gene back into the XpET22b vector as well as into an untouched vector, 
pET23a, and comparing expression levels to see whether the vector was one of the reasons 
expression has been chronically low.   
To increase protein expression levels even further, I varied the environmental 
growth conditions, including the temperature, the level of bacterial growth at which protein 
expression is induced, the strain of E. coli used, and the concentration of isopropyl β-D-1-
thiogalactopyranoside (IPTG) used to induce protein expression.  Each of these variables 
must be optimized for different proteins.  Induction tests were performed to find the most 
favorable conditions for expression of Arabidopsis eIFtr4G and subsequent purification to 
obtain sufficient amounts of protein for antibody production.   
One of the uses for the eIF4G specific antibody will be to help study gene knockout 
plants.  T-DNA insertion mutants have been obtained for all the Arabidopsis genes for 
eIF4G, eIFiso4G, eIF4E and eIFiso4E.  In a mutant plant study similar to what the eIF4G 
antibody is needed for, the effects of knocking out the eIF(iso)4E gene in A. thaliana were 
studied using eIF(iso)4E-specific antibody.  The resulting A. thaliana mutant line did not 
show any morphological or developmental changes in normal growth conditions.  However, 
it was found that when the mutant plant was exposed to potyviruses TuMV and LMV, it was 
resistant to infection, implying that these two potyviruses required eIF(iso)4E to translate the 
viral genome(Duprat 2002).  In contrast, the mutant plants were not resistant to CMV or 
Tomato black ring virus strain ED (TBRV-ED), implying that these two viruses use a different 
initiation factor to translate their genome (Duprat 2002).  In this study, it was important to 
verify the total lack of eIF(iso)4E RNA and protein in order to consider the plant an 
eIF(iso)4E knockout plant line.  Western analysis probes protein with an antibody, which 
detects the protein that the antibody was developed against.  If the eIF(iso)4E gene has been 
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successfully knocked out, the plant extract, when treated with antibody against the protein 
product of the gene, should not react since there is no gene encoding for eIF(iso)4E.  Also 
by Western analysis, comparison of protein levels in different plants can be made when plant 
extract is treated with antibody against the protein of interest.  In this way, one can look at 
the effects of knocking out one initiation factor on the amount of others.  For example, in 
the eIF(iso)4E knockout study, it was found that in knockout plants, the amount of eIF4E 




2  Materials and Methods  
 
2.1  Cloning 
 
The Arabidopsis full-length eIF4G in XpET22b was first cloned by Lauren Harkinson 
and Elizabeth Burks.  eIF4G was cloned in two pieces into the pET22b vector (Novagen), 
but was modified to no longer contain a XbaI site.  This modified vector is now called 
XpET22b.  From this original plasmid DNA, a truncated version of eIF4G was made, 
consisting of the first 609 bp on the 5’ end of the eIF4G gene, called eIFtr4G.  This tr4G 
was generated by cutting at two restriction sites to remove most of the eIF4G gene and only 
retain the N-terminal region.  The XpET22b was relegated closed.  This construct should 
place the his-tag in frame with the eIFtr4G.   A second construct was made by removing the 
N-terminal region with two restriction enzymes and ligating  into pET23a plasmid 
(Novagen).  This construct should also be in frame with the his-tag in pET23a.   Moving the 
N-terminal region into another vector was to be sure that the poor expression in XpET22b 
was not due to some unintended alteration during the modification XpET22b.  The 
truncated contructs were transformed into competent cells for expression to compare for 




2.1.1  Creating the eIFtr4G fragment and insertion into a vector (Figure 8) 
 
 NdeI and HindIII were selected as sites for removal of the N-terminal region of 
AteIF4G from XpET22b for recloning into pET23a.  HindIII was selected to remove the C-
terminal portion of AteIF4G and to religate XpET22b closed so that it only contained the 
N-terminal region.  However, it was found that the eIF4G gene possessed by the Browning 
Laboratory had several point mutations that did not affect the peptide sequence of the 
protein.  The diagrams in this study correspond to those seen in the Browning Lab eIF4G 
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HindIII














*611 bp 3625 bp
Restriction digest: HindIII








Figure 8. Creating the eIFtr4G gene and insertion i nto vectors.
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eIF4G in XpET22b plasmid DNA was obtained from previous stocks, or prepared 
fresh by Mini-prep (QIAgen).  Restriction digest of eIF4G in XpET22b and pET23a vector 
was performed, using NdeI and HindIII restriction enzymes (New England Biolabs) and 
appropriate buffers according to the detailed procedure in Appendix C.  eIF4G in 
XpET22b plasmid DNA was also digested with only HindIII and appropriate buffers 
following the same restriction digest procedure.  
 The restriction digest mixtures were run on a DNA agarose gel.  From the digest of 
pET23a (NdeI/HindIII), the major plasmid vector band (3427 bp) was recovered. From the 
AteIF4G/XpET22b digest (NdeI/HindIII), the N-terminal region (609 bp) was recovered. 
From the AteIF4G/XpET22b digest (HindIII), the plasmid plus the N-terminal region 
(6100 bp) was recovered.  The DNA was recovered from the agarose using Ambion spin 
columns and centrifugation (3000 rpm for x min).  The eluted DNA was ethanol 
precipitated (see Appendix C) and dissolved in 5.5 µl of water.  
 The insertion of the N-terminal AteIF4G fragment (609 bp) into the pET23a vector 
(3427 bp)  was carried out by standard ligation procedures as described in Appendix C. This 
ligation should produce tr4G in pET23a.  The N-terminal AteIF4G fragment retained in 
XpET22b digest (HindIII) is self-ligated and will produce tr4G in XpET22b. 
 The ligation reactions were transformed into E. coli DH5α competent cells as 
described in Appendix C.  Single colonies were selected and plasmids prepared to confirm 
the ligation products were correct.  Plasmid DNA was used for a restriction digest to test 
whether the vector contains the eIFtr4G gene (refer to Appendix C).  NdeI and HindIII 
restriction enzymes were used to screen the plasmids and the restriction digests were 
separated by electrophoresis on a 1% agarose gel.  The correct products for ligation into 
pET23a or retention in XpET22b will show a band at about 609 bp corresponding to the N-
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termial region and no other DNA except the vector.  Positive colonies were confirmed using 
DNA sequencing using T7 promoter and T7 terminator primers, performed by the ICMB 
Core Facility at the University of Texas at Austin. 
 
 
2.1.2  Transformation of plasmid into competent cells 
 
 The tr4G in XpET22b and pET23a were transformed into E. coli  competent cells 
(BL21 or Artic Express, Invitrogen??) using the procedure as described in Appendix C.   
 Begin by adding 2 µl of β-mercaptoethanol to 75 µl of Arctic Express competent 
cells on ice.  Swirl each tube every 2 minutes for 10 minutes.  Then, add 150 ng of plasmid 
DNA and incubate the mixture on ice for 30 minutes.  During the incubation step, preheat 
SOC medium in a 42º water bath.  Heat shock the tubes in the 42º water bath for 20-25 
seconds and incubate the mixture on ice again for 2 minutes.  Then, add 0.9 mL SOC and 
incubate the mixture at 37º for 1 hour, shaking.  Finally, plate about 200 µl of the cell 
mixture on an LB ampicillin plate and incubate at 37º overnight. 
 
2.2  Expression 
 
 The basic expression procedures are identical for both the tr4G/XpET22b and 
tr4G/pET23a are described in detail in Appendix C.   
Several conditions of expression may be optimized such as the strain of E. coli, the 
culture media used, the concentration of IPTG, the temperature pre- and post-induction or 
the time the cells grow post-induction    
 29 
Optimization of IPTG used for induction.  To determine the optimal IPTG 
concentration for induction, a small-scale expression was performed on tr4G/pET23a in 
BL21 cells.  Single colonies were used to innoculate six 250 mL LB cultures containing 
ampicillin (x mg/ml).  The cultures were grown with shaking at 37ºC.  The OD600 was 
checked periodically and when the OD600  reached 0.4-0.6, the cultures were induced with 
IPTG.  Two cultures were each  induced with 0.1 mM IPTG, 0.4 mM IPTG, and 0.5 mM 
IPTG.  After induction, the cultures were incubated with shaking at 30ºC for 3 hours.  The 
cells were harvested by centrifugation and stored at -80ºC.  A small portion of the harvested 
cell pellet was analyzed on a Western blot using anti-His C-terminus-HRP antibody to 
determine if expression occurred.  
 
Comparison of tr4G/XpET22b and tr4G/pET23a expression.  The comparison 
of tr4G in pET23a and tr4G in XpET22b in BL21 cells was performed through side-by-side 
expression under the same conditions using LB media.  After inoculation of six 1 L flasks at 
37ºC shaking, at an OD600 between 0.4 and 0.6, the cultures were both induced to a final 
concentration of 0.5 mM IPTG.  Post-induction, the flasks were incubated at 30ºC for 3 
more hours before harvesting.  A small portion of the harvested cell pellet was analyzed on a 
Western blot using anti-His C-terminus-HRP antibody to determine if expression occurred.   
  
 Expression in Artic Express cells.  The tr4G /XpET22b was transformed into 
Arctic Express cells to look for improvement in tr4G expression levels.  5 mL LB cultures 
containing 20 µg/mL gentamycin were innoculated using single colonies.  The cultures were 
incubated with shaking at 37ºC overnight.  The 5 mL overnight cultures were used to 
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inoculate 1 L LB flasks (without antibiotics) shaken at 37ºC.  The induction ( x mM IPTG??)  
and harvesting of cells were the same as described above. 
 
Media effects on expression.  In order to compare the effects of using different 
types of  media on tr4G expression levels 2XYT and Terrific Broth (TB) media were 
compared to LB media (see Appendix A) were also used.  For the 2XYT media, the same 
procedure as with LB was used.  For TB, the conditions were altered after induction.  After 
induction, the flasks were switched to 28ºC and shaken for 18 hours.   
  
 
2.3  Purification 
 
2.3.1  Purification by His-tag on column 
 
 The bacterial cell pellet was thawed on ice and for each liter of culture used for 
expression, about 10 mL of binding buffer was used.  The cells were completely resuspended 
in ice-cold binding buffer and kept on ice.  This cell mixture was sonicated, making sure the 
cells do not become warm by keeping them on ice, at 3 x 30 seconds of 70%, followed by 2 
x 30 seconds of 90% as described in Appendix A.  The sonicated solution was centrifuged 
at 49,000 rpm (Ti50.2 rotor), for 35 minutes at 4ºC to remove debris and insoluble proteins. 
If inclusion bodies (insoluble protein) are present, a large amount of eIFtr4G protein will be 
present in the pellet.  A portion of the pellet is retained for SDS gel analysis. 
 The supernatant from the centrifugation of 6 L of culture was applied to a 1 mL Ni-
NTA Superflow Resin (QIAgen).  The column was prepared by rinsing with 5-10X column 
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volume of binding buffer to establish a baseline UV reading.  The supernatant was applied to 
the column very slowly.  The column was washed with binding buffer until the UV reading 
returns to the baseline, or levels off to show that the proteins bound loosely to the column 
matrix were removed.  The tr4G was eluted using elution buffer (see Appendix A) and  0.5 
mL fractions were collected until 15-20X the volume of the column was applied.  Each 
fraction was analyzed by the Bradford protein assay and peak fractions of protein were 
pooled.  The pooled fractions are dialyzed against x ml of buffer N’ + 0.1 M KCl buffer (see 
Appendix A) in 20 mm tubing at 4ºC overnight.  The protein sample was aliquoted (sizes?) 
and stored at -80ºC.  If the same column is to be used again it should be regenerated as 
described in Appendix C.  
The pooled protein sample was analyzed for purity by 12.5 % SDS PAGE and 
western blotting as described in Appendix C.   
The pooled protein was concentrated using Ambion spin columns in the JA-20 
rotor, at 4ºC at a speed of 9,000 rpm at 15 minutes intervals until the desired level of 
concentration was achieved. 
 
2.3.2  Removal of contaminants by ion exchange chromatography 
 
 Further purification of the tr4G was carried out using phosphocellculose (PC) and 
diethylaminoethanol (DEAE) ion exchange columns.  
Initial small scale purification was performed (0.5 mL columns) to determine if 
contaminants and eIFtr4G may be separated based on ion exchange columnes.  The 
columns were prepared by  washing with N’ +0.1 M KCl buffer (5-10x column volumes).  
The protein sample was applied and the column was washed with N’ +0.1 M KCl buffer.  
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The protein was eluted using N’ + 0.2 M KCl buffer (see Appendix A) and 0.25 mL 
fractions were collected.  The resulting fractions were analyzed for purity by12.5% SDS-
PAGE. 
 Further purification was tested using  a 1 mL HisTrap HP FPLC column 
(Amersham) and elution with an imidazole concentration gradient.  All buffers were filtered 
through a 0.2 µm membrane.  The column was washed with 5X the column volume of de-
ionized water at a rate of 1 mL/min and the flow rate held constant throughout the entire 
run.  The column was equilibrated with binding buffer (~5 column volumes).  The protein 
sample was injected and the column was then washed with 10-15X volumes of binding 
buffer.  The protein was eluted using a gradient from 20 mM to 250 mM imidazole over 10 
minutes, collecting 0.5 mL fractions.  Any remaining proteins were removed by elution with 
500 mM imidazole.  The column was  washed with 5-10X column volumes of de-ionized 
water, 5-10X 1.5 M NaCl, 5-10X de-ionized water, and then stored in 20% ethanol.   
The purity was assessed by 12.5% SDS-PAGE and the fractions containing the 
highest purity tr4G were pooled and dialyzed overnight in N’ + 0.1 M KCl at 4ºC.  The 
protein was analyzed by Bradford for protein concentration, aliquoted and stored at -80ºC. 
 
2.3.3  Analysis of protein by mass spectroscopy 
 
The gel apparatus was cleaned with 20% SDS and de-ionized water and stored in 
clean bags under a chemical hood.  Disposable materials, such as pipette tips, razor blades 
and gloves were brand new and changed each time it was exposed to the environment 
outside of the hood.  All solutions must be filter sterilized.  The protein sample was 
separated on a NuPAGE Novex Bis-Tris Gel (Invitrogen) using the XCell SureLock Mini-
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Cell apparatus.  The sample was prepared with NuPAGE sample buffer (4X), 1 µl 2M DTT, 
and de-ionized water to a total volume of 20 µl .  This sample was heated at 75ºC for 10 
minutes.   The XCell gel apparatus was assembled and filled with NuPAGE running buffer.  
Prior to sample application, 0.5 mL NuPAGE Antioxidant Solution added to the front 
chamber.  A protein molecular weight marker was also applied to the gel   The gel was run at 
200 V until the dye marker reach the bottom of the gel. 
 Precautions must be taken to prevent contamination of the sample, gel, buffer or 
apparausThe gel was taken out from the XCell apparatus and placed fixer solution provided 
with the NuPAGE kit, and shaken, for 20 minutes.  The gel is transferred to 25 mL of 
NuPAGE Stain A, shakenfor 10 minutes.  2 mL of NuPAGE Stain B is added and shaken 
for an additional 30 minutes.  The gel was destained and then shaken in de-ionized water for 
20 minutes, or until the protein bands were clearly visible.  Bands of interest are cut out, 
using a sterile razor blade, and placed in 1.5 mL eppendorf tubes.  The bands were futher 
destained with 1 mL of 50% methanol for 20 minutes.  This step of destain may be repeated 
if necessary  to remove residual dye.  The gel band was then dehydrated by removing the 
50% methanol and addition of 1 mL acetonitrile for 5 minutes.  This step was repeated with 
fresh acetonitrile for 10 minutes.  The acetonitrile was removed and 0.5 mL of 100 mM 
DTT added for 30 minutes.  The DTT was removed and 0.5 mL of 100 mM iodoacetamide 
added for 30 minutes.  The iodoacetaamide was removed and 0.5 mL 100 mM ammonium 
bicarbonate added for 30 minutes.  The aceonitrile step was repeated for 30 min and then all 
liquid removed.  The gel band was air dried for 10-15 minutes.  To the dried tube 20 µl 
trypsin (conc?) was added and placed on ice for 5 minutes.  The trypsin was removed and 10 
µl of 100 mM ammonium bicarbonate was added.  The reaction was incubated overnight at 
37ºC. 
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 The reactions were centrifuged briefly to get the liquid and gel bands to the bottom 
of the tube and 10 µl of formic acid was added and incubation continued at room 
temperature for 15 minutes to inactivate the trypsin.  A 15 µl aliquot of the solution was 
removed and placed into a clean 1.5 mL eppendorf tube.  Add an additional 10 µl of formic 
acid to the sample to increase the sample volume.  The protein sample prepared by this 
method was analyzed by mass spectroscopy for analysis (performed at the ICMB Core 




3  Results 
 
Introduction of Results 
 
The main problem in reaching the goal of developing eIF4G-specific antibodies was 
obtaining enough eIF4G protein.  Because AteIF4G is a relatively large protein (180 kDa) 
and very prone to degradation (Browning 1996), it has been difficult to attain sufficient 
amounts of this protein.  Previous work I have done has included protein expression of 
Arabidopsis eIF4F complex (both eIF4G and eIF4E together) and purification for antibody 
production.  In achieving that goal, I faced many difficulties with the eIF4G component 
because of its low expression levels and propensity for degradation.  We were able to 
increase the yield of full-length eIF4G by combining cells producing eIF4E and cells 
producing eIF4G before breaking open the cells.  By mixing eIF4E and eIF4G expressing 
cells before the cells were lysed, when the proteins were released, they stabilized each other 
by presumably encouraging correct folding and overall stability.  We were able to take 
advantage of the stabilizing effect of eIF4E binding to eIF4G, as well as the complex’s 
increased affinity for the 5’-cap structure in the purification of the eIF4F complex from 
other proteins naturally produced in E. coli cells.  The use of the affinity matrix, m7GTP 
Sepharose, which mimics the cap and binds eIF4E, also retains any proteins bound to 
eIF4E, such as eIF4G.  It is important to attain protein without a large amount of 
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contaminants, because when antibodies are made, they are made to all proteins in the sample 
provided.  There is no way to predict the reactivity of the host animal in which the 
antibodies are raised to certain proteins over others.  Therefore, with contaminants, one runs 
the risk that the contaminant may have much better antigenicity, making the majority of 
antibodies produced against the contaminant and not the protein of interest, in this case 
eIF4G.  Thus, using an antibody for identification of a protein that contains a contaminant 
may produce false results or at the very least a high background of non-specific binding to 
the antibody preparation.   
The biggest hurdle in this previous project was expressing eIF4F; even with the 
eIF4E-eIF4G stabilization, it was still difficult to obtain enough eIF4F complex.  The main 
reason for this is thought to be the large size of the eIF4G, making it less likely that the 
translational machinery stays on the mRNA long enough to finish translating eIF4G into 
protein or that the protein itself is toxic to E. coli.  Therefore, I tried to improve the situation 
using a co-expression approach.  The eIFs4G gene and eIF4E gene were made into a 
dicistronic construct, where the two genes are adjacent to each other.  Whereas in the 
previous procedure the eIF4G and eIF4E proteins were expressed in separate cells and then 
combined after cells were broken open, with the dicistronic construct, eIF4E and eIFs4G 
will be expressed in the same cell, one after the other.  Because the two proteins will be 
expressed in such close proximity to each other, they should form the stabilized eIF4F 
complex more quickly, and degradation should be inhibited.  In comparing the two different 
methods of eIF4F expression, there was not a significant difference in protein yield.  
However, in the end, this Arabidopsis eIF4F complex was successfully expressed at a very low 
level and enough protein obtained to produce eIF4F complex antibodies.   
 37 
While the eIF4F antibody has been very useful, there is also a need for Arabidopsis 
eIF4G-specific antibody.  The Arabidopsis eIF4F-specific complex, while it recognizes eIF4G 
protein, also recognizes eIF4E, making it inadequate for pull downs and identifying eIF4G.  
In developing eIF4G antibody, the same difficulties that were faced in eIF4F antibody 
production will apply; however, because the antibody will be specific to eIF4G, we cannot 
use eIF4E to stabilize and increase the protein yield of eIF4G.  To address this need, instead 
of using a full-length eIF4G gene, I constructed a short version of eIF4G (eIFs4G) that 
consisted of the N-terminal half of eIF4G, producing a protein that is only 542 amino acids 
long.  Theoretically, if the protein is smaller, there is a greater chance that the entire protein 
will be produced before the translational machinery falls off the mRNA, increasing protein 
yield and it is possible that a shorter version of eIF4G maybe less toxic to E. coli.  Because 
we are using the eIF4F protein for antibody production, the eIF4G does not need to be full-
length, as antibodies directed against a portion of the protein will still be able to recognize 
the full length eIF4G effectively.     
 
 
3.1  Cloning eIFtr4G 
 
Possible factors that could cause the consistently low expression levels of eIF4G 
include: 1. the plasmid vector, XpET22b; 2. the strain of E. coli is not optimal for expression; 
3. the growth media and/or conditions for the bacteria is suboptimal; and 4. the toxicity of 
eIF4G to E. coli.   
A truncated version of eIF4G, named truncated eIF4G (eIFtr4G), that consisted of 
the first 223 amino acids of the N-terminus of eIF4G was engineered by two methods.  This 
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N-terminal region was selected because it is relatively un-conserved among different species,  
even plants, making the antibody specific to Arabidopsis eIF4G.  This gene was specifically 
engineered to produce the eIFtr4G protein with a protein tag of six histidines on the C-
terminal end to  simplify purification  on a Ni-NTA column.   
Full-length eIF4G, originally in XpET22b, was digested in order to yield eIFtr4G.  For its 
insertion into the pET23a vector, both the pET23a vector and eIF4G in XpET22b were 
digested with NdeI and HindIII restriction enzymes.  As shown in Figure 9a, the restriction 
digests were separated on a DNA agarose gel.  Lane 1 shows the DNA size marker while 
Lane 2 contains pET23a digest (NdeI/HindIII), with the linearized plasmid of 3427 bp. 
Lane 4 contains the eIF4G in XpET22b digest (NdeI/HindIII) and should contain DNA 














  a b 
609  bp  * 
3427  bp  * 
3625  bp  
5380  bp  
6.1  Kb * 
9.7 Kb  
3.6 Kb  
Figure 9  . Restriction digest of 4G in XpET22b and pET23a vec tor   .  (a) Restriction digest using   
NdeI  and   HindIII  , for the insertion of eIFtr4G into pET23a. Lane 1: DNA marker.   Lane 2: pET23a   
digest. Lane 3: empty. Lane 4: eIF4G in XpET22b digest, with the  pi ce of interest starred.  (b)   
Restriction digest using   HindIII  , for eIFtr4G in XpET22b. Lane 1: DNA marker. Lane 2: eIFtr4G in  
XpET22b digest, with the piece of interest starred.  
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The desired fragments pET23a (3427 bp) and eIFtr4G (609 bp) were recovered from the gel 
and ethanol precipitated.  The DNA sequence was confirmed. 
 For the creation of eIFtr4G in XpET22b, full-length eIF4G in XpET22b was 
digested using HindIII restriction enzyme.  In Figure 9b, the results of the restriction digest 
are shown, for eIF4G in XpET22b digested with Hind III.  The digest shows 3 bands: 
undigested full-length eIF4G in XpET22b of about 9.7 Kb, the front third of eIF4G in 
XpET22b at about 6.1 Kb, and the last two-thirds of eIF4G at about 3.6 Kb.  The desired 
band is the one containing the first third of eIF4G (6.1 Kb).  This DNA fragment was then 
self-ligated and sequenced in order to confirm the sequence of eIFtr4G.  The eIFtr4G final 
protein will have the amino acid sequence and properties shown in Appendix B. 
 
3.2 Finding the optimal IPTG concentration for induction 
 























Figure 10 . IPTG concentration induction test.  This Western 
blot, performed on crude culture samples, used an Arabidopsis 
recombinant eIF4F primary antibody for eIFtr4G protein 
identification (eIFtr4G in XpET23a in BL21 cells, raised in LB 
Broth media). Lane 1: [IPTG] = 0.1 mM . Lane 2: [IPTG] = 0.2 mM . 








A preliminary protein expression was performed, using the eIFtr4G/pET23 
construct to determine the optimum concentration of IPTG  for induction.  Cultures were 
inoculated with eIFtr4G/pET23a in BL21 competent cells according to the protocol 
described in the methods section.  Samples were taken after 3 hours of induction and used 
to determine the best IPTG concentration through Western blot (see Figure 10).  Western 
blot was performed using the rabbit anti-Arabidopsis recombinant eIF4F antibody.  From 
this Western blot, one may see that with increasing IPTG concentration an increasing 
amount of protein is produced.  Since the 0.5 mM IPTG concentration yielded the most 
eIFtr4G protein, it can be concluded that 0.5 mM IPTG is the best condition for induction.  
Thus, in all future preparations, induction was performed with 0.5 mM IPTG. 
To confirm the expression of AteIFtr4G,  a protein extract was prepared and 
purified on a Ni-NTA column as described in the methods section.  Peak fractions were 
collected and combined.  The pooled fractions were analyzed on 12.5% SDS-page gel (Figure 
11a) as well as by Western blot, using an anti-His C-terminal-HRP antibody, as shown in 
Figure 11b.  In the protein gel, the single clear band at 24 kDa indicates that a protein of the 







Figure 11 .  Pooled IPTG induction test. 
eIFtr4G in pET23a in BL21 cells, expressed in 
LB Broth media. (a) sample on a 12.5% SDS - 
page gel, showing the major band at about 24 
kDa , where eIFtr4G should be. (b) sample 
analyzed by Western blot, showing a single 









as eIFtr4G, the Western blot was performed, probing for proteins that contain a His-tag.  
The clear, single band on the Western blot confirms that the band seen on the protein gel 
was in fact eIFtr4G.  Using Bradford analysis, the total protein content of the pooled 
fractions was approximately 0.1186 mg from 750 mL of culture.  This yield is low and it is 
possible that the majority of the expression protein may be present in insoluble material. 
 
 
3.3 Test for inclusion bodies during protein expression 
 
 In order to assess whether there is formation of insoluble protein in inclusion bodies, 
a 3 L LB Broth culture was inoculated (using eIFtr4G in XpET22b in BL21 cells) and 
induced with 0.5 mM IPTG.  According to the methods described above, the bacteria was 
harvested and the protein was purified.  A crude sample of bacterial pellet was taken after 
harvest.  This pellet sample was analyzed alongside the pooled purified fractions in a 
Western blot, using the anti-His C-terminal-HRP antibody, as shown in Figure 12.  In the 
crude pellet sample, a small amount of eIFtr4G protein was detected, while, in the pooled 
peak fractions, a very large band indicating presence of eIFtr4G protein and a band showing 
 
24 kDa*
75 kDa Figure 12. Test for inclusion bodies during  
expression. eIFtr4G in XpET22b was expressed in  
BL21 cells.  Pellet and pooled fractions were  
compared by Western blot analysis, probed with  
anti - His C - terminus - HRP antibody.  Lane 1: crude  
cell pellet. Lane 2: pooled fractions. 
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a protein of about 75 kDa were detected.  Therefore, it is possible that there are a small 
amount of inclusion bodies, but it is more likely that some cells were not completely broken 
open during sonication, so that some protein was trapped inside cells. Bradford analysis 
showed that the pooled fractions contained 1.894 mg of protein from 3 L of cells. 
 
 
3.4  Comparing AteIFtr4G expression levels in different vectors 
 
 One of the possible reasons eIF4G protein expression levels are so low could be due 
to the alteration of the pET22b vector, to XpET22b.  Some undesired mutation may have 
occurred during the alternation which could interfere with the ability to promote robust 
translation.  To test this, comparisons were made between expression levels of eIFtr4G in 
XpET22b and in pET23a, an unaltered vector.  Identical conditions were used: LB Broth 
media in six 1 L cultures each, induction with a total IPTG concentration of 0.5 mM for 3 
hours at 30ºC, and harvesting and purification according to the basic procedure described in 
the methods section.  Peak fractions from both preparations were pooled separately and 
analyzed using Bradford analysis.  The preparation using eIFtr4G in XpET22b contained 
2.284 mg, while the one using eIFtr4G in pET23a yielded 3.893 mg.   
From these results, there is an obvious improvement when eIFtr4G gene was 
inserted into an unaltered vector, pET23a.  However, while this direct comparison shows 
eIFtr4G in pET23a produced more protein than when in XpET22b, one could also look at 
the previous induction test, which used eIFtr4G in pET23a, and the inclusion body test, 
using eIFtr4G in XpET22b.  In the induction test preparation, 0.1186 mg was purified from 
1.5 L of culture (0.08 mg/L) using pET23a, while in the inclusion body test, 1.894 mg was 
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obtained from 3 L of culture (0.65 mg/L) using XpET22b.  From this comparison, eIFtr4G 
in XpET22b was much more productive.  This discrepancy from the direct comparison 
could be due to several factors: 1) inexperience because the induction test was the first 
preparation done, 2) the induction test was induced at a higher OD600, when less cells were in 
a productive state, and 3) the difference due to the use of 250 mL cultures for the induction 
test versus 1 L cultures for the inclusion body test.  Based on these inconsistencies between 
the two tests, the direct comparison, done side-by-side, gives a much more representative 
picture of which vector results in better protein expression levels.  Therefore, future 
preparations all used the eIFtr4G in pET23a construct.  However, it should be noted that 
the difference is quite small and there is likely little or no difference in the constructs. 
 
 
3.5  Comparing AteIFtr4G expression using different E. coli strains 
 
E. coli BL21 cells are traditionally used for protein expression in the Browning 
laboratory and for most proteins good expression is obtained.  E. coli Arctic Express cells 
(Novagen) are engineered to express at cold temperatures (4ºC).  At this temperature, 
proteins will be expressed slower, but the cell also produces cold-loving chaperonins, which 
help to fold proteins into the correct, stable configuration, and rare tRNAs, which reduces 
pausing of the translational apparatus, reducing its dissociation from the mRNA.  Thus, 
although the Arctic Express cells produce protein at a lower rate, they should ultimately 
produce more correctly folded and stable protein.  This strain will be used to determine if 
the production of eIFtr4G may be improved. 
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 Six 1 L cultures of LB Broth were inoculated with eIFtr4G in XpET22b in Arctic 
Express cells.  Incubation and expression conditions were as described by the manufacturer 
for Arctic Express cells (Novagen).  The cells were harvested and the protein purified by Ni-
NTA column.  The pooled peak fractions were run on a 12.5% SDS-page gel to check for 
eIFtr4G protein expression.  However, there was no detectable eIFtr4G present.  This effect 
could have been due in part to either the cold temperature, which may have lowered already 
low protein expression levels or the problem with eIFtr4G protein expression is not due to 
misfolding.  Therefore, Arctic Express E. coli cells did not improve eIFtr4G protein 
expression in comparison to BL21 cells.   
 
 
3.6 Comparing AteIFtr4G expression in different growth media and temperature 
 
The growth media was varied to find the conditions that encourage production of 
the most eIFtr4G protein.  The most basic growth medium is LB, which contains all 
necessary nutrients for bacterial cells to grow.  Another medium that will be tried will be 
2xYT medium, which contains the minimal nutrients for cell growth, thus slowing down 
expression, but increasing folding time for proteins following expression to increase stability.  
Also, Terrific Broth (TB) will be tested, which provides a very robust environment for 
bacteria with excessive nutrients, to encourage an increase in global protein expression 
levels.  
To compare Terrific Broth media expression versus that observed in LB Broth 
media, the same volume to surface area ratio was maintained by using six 1 L media in 6 L 










used for expression.  Induction of expression in TB broth was a final IPTG concentration of 
0.5 mM, at 28ºC overnight, for about 18 hours.  Purification of protein was performed as 
described for a basic Ni-NTA column.  The pooled fractions were analyzed on a 12.5% 
SDS-page gel (Figure 13a).  The gel revealed significant levels of contaminants in addition to 
eIFtr4G, one of which is similar in size to eIFtr4G.  To distinguish the protein of interest 
from contaminants, the sample was analyzed with Western blot, probed with anti-His C-
terminal-HRP antibody (Figure 13b).  This Western blot revealed that eIFtr4G protein was 
the smaller protein in the doublet, running as a 24 kDa protein, while the two other protein 
bands, ran at about 28 kDa and 73 kDa.   
These contaminant bands were not seen in preparations using LB Broth media and an 
induction temperature of 30ºC.  The appearance of these bands could be due to the overall, 
large increase in global protein expression.  Using Bradford analysis, the peak fractions of 
this preparation yielded 18.970 mg of protein.  However, one must also consider that a large 
portion of this protein consists of contaminants.  While these proteins could have also been 
present in LB broth preparations, they may not have been visible with that level of protein 
expression.  In order to be able to assess by how much Terrific Broth and the new overnight 
  a b 
24  kDa * 
73  kDa 
28  kDa 
Figure 1 3. eIFtr4G in pET23a was expressed in  
BL21 cells, using Terrific Broth media and  
modified induction conditions  .  (a) Peak  
fractions were pooled and run on a 12.5% SDS - 
page gel.  Lane 1: Protein molecular weight  
marker. Lane 2: peak fractions show the presence  
of eIFtr4G protein in addition to 2 contaminants.  
(b) Peak fractions were analyzed by Western blot,  
probed with anti - His C - terminus - HRP antibody.  
Lane 1: peak fractions, identify the 24  kDa protein  
as the eIFtr4G protein and the 73  kDa and 28  kDa 
proteins as contaminants. 
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induction condition improve eIFtr4G protein expression, purification of the protein of 
interest from contaminants was necessary.   
 
 
3.7 Purification of AteIFtr4G 
 
 To separate the contaminants from eIFtr4G protein, we assumed that they had 
different binding affinity for the Ni-NTA resin.  Because the eIFtr4G protein is engineered 
to have six His residues, it should bind the resin with the greatest affinity.  The peak 
fractions were applied over a Ni-NTA column, which was then washed with 20X column 
volumes of binding buffer, making sure that all proteins not bound to the matrix would be 
washed out.  Then, instead of proceeding to the normal elution step, a second wash was 
applied, binding buffer containing 50 mM imidazole for 15X column volumes, intended to 
wash off proteins bound loosely to the matrix, leaving those that bind very tightly to the 
matrix.  Then, elution using the elution buffer, with 250 mM imidazole, bumps off all 
remaining proteins on the column.  From each step, peak fractions were pooled, and then 
run on a 12.5% SDS-page gel (Figure 14).  In this gel, the 20 mM imidazole wash eliminated 
some of the 28 kDa and 73 kDa contaminants.  Therefore, one of the reasons that there was 
so much contamination in the initial purification was due to insufficient washing at low 
imidazole  after the extract was applied to the column.  The 50 mM imidazole wash 
eliminated the majority of the remaining 28 kDa and 73 kDa proteins, as well as some of the 
eIFtr4G protein (24 kDa).  The eluted protein from the 250 mM imidazole wash contained 











eIFtr4G had the greatest affinity for the Ni-NTA matrix, there was not a clear separation 
between eIFtr4G and the contaminanting proteins; about one-third of eIFtr4G protein is 
also lost at the concentration of imidazole that removes most of the contaminants. 
The relatively pure protein sample obtained from the elution step contained 7 mg of 
protein.  Thus, there is a marked increase in eIFtr4G protein expression when expressed in 
Terrific Broth and using overnight induction when compared to LB Broth.  However, in this 
7 mg, there is still ~20% contaminanting proteins.   
A second protein preparation identical to the one described above using Terrific 
Broth was performed, and after the two purification steps on the Ni-NTA column, Bradford 
assay showed ~7 mg of protein.  This sample was run on 12.5% SDS-page gel (Figure 15) 
and results were consistent with those seen previously, the same contaminants were found at 
about the same levels as previously observed. 
While the additional purification of peak fractions on a Ni-NTA column reduced 
contaminant levels, further purification was still needed.  One way that they could be further 
separated could be based on the binding affinity of the desired protein (eIFtr4G) or the 




Figure 14. Separation of contaminants from 
eIFtr4G protein over a Ni -NTA column. After 
three successive washes, peak fractions were 
pooled and run on a 12.5% SDS -page gel.
Lane 1: protein molecular weight marker. Lane 
2: peak fractions following a wash with binding 
buffer (20 mM imidazole ). Lane 3: peak 
fractions following a wash with binding buffer 
(50 mM imidazole ). Lane 4: peak fractions 










binding positively charged proteins.  AteIFtr4G could potentially, selectively bind PC as the 
protein’s predicted isoelectric point (pI) is basic, 9.82.  On the other hand, AteIFtr4G could 
also selectively bind DEAE as it contains a string of acids on the N-terminal end of the 
protein.   If the contaminants do not bind either PC or DEAE and the AteIFtr4G does, then 
the contaminants will be removed in the wash.  Conversely, if the contaminants bind and 
AteIFtr4G does not, then the desired protein will be recovered in the run through of the 
column. 
Small scale purifications were performed on both types of columns and comparisons were 
made between the run through, the re-equilibrating wash, and the elution fractions on a 
12.5% SDS-page gel (Figure 16).  The PC and DEAE column run-throughs contained most 
of the eIFtr4G and contaminant proteins, while the remaining protein was found in the re-
equilibration wash.  Therefore, neither eIFtr4G nor the contaminant proteins showed 
differential binding affinity for PC or DEAE.  
Since there is no way to separate eIFtr4G and contaminants by ion exchange 
chromatograpy,  the Ni binding affinity column will be used with a gradient to try and 
separate the proteins based on their different affinities.  To get a better separation of 
contaminants and eIFtr4G protein, an imidazole gradient, from 20 mM to 250 mM was 
 
24  kDa * 
73  kDa 
28  kDa 
Figure 15. eIFtr4G in pET23a was expressed in BL21 cells, using Terrific  
Broth media and modified induction conditions  . Peak fractions were  
pooled and run on a 12.5% SDS - page gel.  Lane 1: Protein molecular weight  
marker. Lane 2: peak fractions show the presence of eIFtr4G prot ein in  














applied over a HisTrap HP column using FPLC, as described in the methods.  The ~14 mg 
of protein from the combination of two preparations grown in Terrific Broth were applied 
over the column.  In Figure 17a, the UV analysis of fractions during elution is graphed along 
with the imidazole gradient.  The peaks in the UV reading correlate to the specific protein 
coming off by matching the corresponding fractions to the protein seen on a protein gel.  
The peak fractions were immediately run on a 12.5% SDS-page gel (Figure 17b) to determine 
which fractions contained the purest eIFtr4G.  The peak fractions were pooled and dialyzed.  
The first, small peak on the UV graph, corresponds to the first protein that came off of the 
FPLC column, the 73 kDa protein with little overlap with eIFtr4G.  The large, second peak 
corresponds to both the 28 kDa contaminant as well as eIFtr4G.  Over the course of the 
gradient, the gel shows that while the contaminant binds less well to the column than 















































Figure 16. Separation of contaminants from eIFtr4G protein over PC and DEAE columns.  
Fractions collected during loading, wash and elution were collected and run on a 12.5% SDS-page 
gel.  Lane 1: protein molecular weight marker.  Lane 2: PC column run through.  Lane 3: PC 
column wash.  Lanes 4-7: PC column elution.  Lane 8: DEAE run through. Lane 9: DEAE wash. 

















of the total eIFtr4G in the sample for purity.  The most pure fractions were pooled and 
Bradford assay indicated a total of ~5 mg of protein. 
 
 
3.8 Mass Spectroscopy 
 
This new purification step resulted in a much cleaner protein sample, containing 
predominantly eIFtr4G protein; however, before raising antibodies it was desirable to 
confirm that the major band was eIFtr4G and to determine the identity of the remaining  
  
24  kDa * 
73  kDa 
28  kDa 
a
b 
Figure 17.  HisTrap  HP FPLC column using an  imidazole  gradient.  eIFtr4G in pET23a in BL21 cells were raised  
using Terrific Broth media. (a) UV reading was graphed against f raction number during elution. The black line  
indicates the  imidazole gradient, from 20 - 250  mM , while the blue line indicates the UV reading.  Each bump  
represents a different protein’s elution. These fractions were r un on a 12.5% SDS - page gel to determine the identity  
of the protein being eluted. (b) Elution fractions were run on a 12.5% SDS - page gel. Lane 1: protein molecular  














contaminants.  To prepare the protein for mass spectroscopy, it was run on a NuPAGE 
Novex Bis-Tris gel and prepared as per the methods described above.  When run on the Bis-
Tris gel, a different banding pattern was seen when compared to previous 12.5% SDS-page 
gels.  A cartoon of the banding patterns is shown in Figure 18.  This is not entirely surprising 
as proteins may run differently on different gels due to different interactions with the gel and 
chemical environment.  Results indicated that the major band (a) was in fact eIFtr4G 
protein, the band just below (b) was a degradation product of eIFtr4G, the next minor band 
was E.coli secB (c)protein with trace amounts of eIFtr4G, and the last band (d) was another 
degradation product of eIFtr4G.  Therefore, while there is a confirmed contaminant, the 
overall amount of secB in comparison to the amount of eIFtr4G protein is insignificant and 











Figure 18.  Protein banding patterns on Bis-Tris gel s versus 12.5% SDS-page gels.  A Bis-Tris
gel was required for mass spectroscopy and showed a different banding pattern than usually seen on 
12.5% SDS-page gels.  Each band was analyzed using mass spectroscopy and identities were 
determined.  (a) eIFtr4G. (b) eIFtr4G degradation products. (c) E. coli secB and eIFtr4G degradation 
products. (d) eIFtr4G degradation products.
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The mass spectroscopy results showed that only a very small portion of the final protein 
sample contained contaminant protein.  The very faint band on the Bis-Tris gel that 
represented this contaminant protein did not run in the same pattern that was normally seen 
on a 12.5% SDS-page gel (refer to Figure 18).  There are four bands seen on the Bis-Tris gel, 
while there are only two bands on the 12.5% SDS-page gel, indicating that several bands that 
usually run together on the 12.5% SDS-page gel are separated out on the Bis-Tris gel.  In 
trying to determine which band on the 12.5% SDS-page gel corresponded to E. coli secB 
protein, I considered several factors.  Looking at Figure 13, by performing the Western blot 
alongside the 12.5% SDS-page gel, one may determine that the 28 kDa protein is a 
contaminant, as it does not bind with anti-His C-terminus HRP antibody.  Also, it cannot be 
a degradation product of eIFtr4G as it is larger in size than the band that does associate with 
the antibody. From mass spectroscopy results, one knows that only eIFtr4G and E. coli secB 
proteins are present in the sample.  Thus, the only possible identity of the 28 kDa band is 
secB protein, while the eIFtr4G band contained full-length eIFtr4G and its degradation 
products.  However, it was somewhat unexpected as the secB band seen on the Bis-Tris gel 








From the results obtained, out of the conditions tested, the expression levels maximizing 
eIFtr4G protein expression were found to be 1) a high IPTG concentration, 0.5 mM; 2) a 
gene construct which used an unaltered vector, in this case pET23a; 3) using BL21 E. coli 
cells; 4) raising cultures in Terrific Broth; and 5) inducing cells overnight at a temperature of 
28°C.  It was confirmed that AteIFtr4G protein does not form inclusion bodies in solution, 
thus eliminating this as a possible factor in low protein yield.   
While there is basal expression of AteIFtr4G protein at low concentrations of IPTG 
during induction, results clearly showed a marked increase in expression levels as IPTG 
concentration was increased.  Although this increased IPTG concentration increased 
eIFtr4G protein expression, it also increased global E. coli protein expression, increasing the 
amount of contaminant proteins.  While this is a drawback, it is outweighed by the benefit of 
increasing tr4G protein expression, reducing the number of protein preparations that would 
have to be done to accumulate the same amount of protein.  Then, almost all of the 
contaminants can be removed through an extra purification step.  If a similar obstacle arises 
in the future in which protein expression is very low, increasing IPTG concentration could 
help.  Conversely, if protein expression levels are high, with a high level of contaminant 
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protein expression as well, one may consider attempting to reduce IPTG concentration 
during induction for more pure protein expression. 
Because there was a modest improvement of protein expression levels when the 
AteIFtr4G gene was in pET23a, as compared to XpET22b, one may conclude that deleting 
the XbaI restriction site in pET22b may have compromised the vector’s overall functioning.  
Knowing this, better expression of full-length AteIF4G protein may be possible if the gene 
was excised and inserted into a new vector.  This general principle could also be applied to 
other proteins that are troublesome to express; placing the gene in a fresh vector that has not 
been altered may eliminate the interference of a reworked vector on protein expression. 
Another hypothesized cause of low AteIFtr4G protein expression was the misfolding 
and degradation of protein.  Therefore, to test this, I compared the differences in protein 
yield using two different E.coli strains: BL21 and Arctic Express.  BL21 is a standard E. coli 
strain used in protein expression, while the Arctic Express strain is special in that it encodes 
cold-loving chaperonins that help the folding of the protein being expressed during 
induction at 4°C.  Theoretically, using the Arctic Express cells should decrease the amount 
of contaminanting proteins, while helping the stability of the protein of interest.  Results 
indicated that using Arctic Express cells did not show any improvement in AteIFtr4G 
protein expression and actually decreased the amount of protein produced.  This outcome 
may imply that AteIFtr4G does not have much difficulty with protein folding.  This would 
not be surprising as eIFtr4G is not an especially large protein.  However, one may not 
conclude that this is case as the temperature change to 4°C could have played a role in the 
initial difficulty of protein expression, which would also not be surprising as eIF4G and 
eIFtr4G proteins seem to be fragile and particular about the condition and environment 
during protein expression. 
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When media and induction temperature and duration were varied, a large difference in 
protein expression level was seen.  Growing cultures in Terrific Broth at an induction 
temperature of 28°C overnight, versus using LB Broth at an induction temperature of 30°C 
for 3 hours, resulted in a very noticeable increase in global protein expression.  Using 6 L of 
LB Broth to raise eIFtr4G in pET23a at standard induction procedures yielded 3.893 mg of 
relatively pure protein.  Using 6 L of Terrific Broth to raise the same construct at modified 
induction procedures yielded 7.032 mg in one preparation and 6.910 mg in another.  
Therefore, using Terrific Broth and the modified induction environment produced about a 
180% increase in eIFtr4G protein expression.  Since this study’s main goal was to increase 
eIFtr4G protein expression, temperature, duration and media were all altered from standard 
procedure at one time.  As a group of changes, an obvious effect was seen.  However, future 
studies could further elucidate the effects of each modification individually, testing whether a 
single modification caused most of the optimization, or whether the factors worked 
cooperatively to increase protein expression levels.   
Increasing global protein expression using modified media and induction conditions 
causes the same problem seen with increasing IPTG concentration for induction earlier, in 
that while an increase in the protein of interest is seen, an increase in contaminant proteins 
are also observed.  For AteIFtr4G, however, this problem was solved by the addition of a 
FPLC purification step using an imidazole gradient on a Ni column.  
Throughout the purification of AteIFtr4G protein from contaminants, when run on a 
12.5% SDS-page gel, 2 contaminant bands were seen at 28 kDa and 73 kDa.  All three bands 
showed similar binding affinity to Ni-NTA matrix, as shown through their overlapping 
elution when using 20 mM, 50 mM, and 250 mM imidazole washes (see Figure 14).  These 
three elution steps also showed that the 73 kDa protein had the lowest binding affinity, then 
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the 28 kDa protein, and eIFtr4G had the greatest affinity.  This is expected as the eIFtr4G 
protein was engineered to contain a His-tag at the C-terminal end of the protein, while the 
contaminant proteins should not. 
One way to purify eIFtr4G was to separate it from the contaminant proteins based on 
charge.  This was attempted through the use of PC, which is negatively charged, and DEAE, 
which is positively charged.  However, results showed that neither eIFtr4G nor the 
contaminant proteins bound either PC or DEAE. 
The contaminants were successfully removed by the use of a HisTrap-HP FPLC 
column, applying an imidazole gradient to create clearer separation of eIFtr4G and 
contaminants.  By applying the imizadole gradient, the 73 kDa contaminant was removed, 
while the 28 kDa and eIFr4G proteins eluted together, suggesting  very similar binding 
affinity.  Fractions were selected that contained the most eIFtr4G, even though a large 
portion of the total eIFtr4G protein was lost in fractions that also contained considerable 
amount of the 28 kDa contaminant.  The pooled fractions were then analyzed by mass 
spectroscopy and were determined to be mostly eIFtr4G, with trace amounts of E. coli secB 
protein.  This sample, containing ~5 mg AteIFtr4G protein was used to raise antibodies in 
rabbits. 
Developing eIF4G antibody will provide the tools to probe for levels of eIF4G in 
knockout eIF4G and eIF(iso)4G Arabadopsis plants, or to perform immunoprecipitation, to 
pull down proteins or RNA complexes that are associated with eIF4G.  The strategies used 
in this study to increase protein expression could be applied to other proteins that are also 
difficult to express.  Finally, the results of these projects may contribute to continuing and 
future projects that cannot yet be foreseen, but will undoubtedly clarify the roles of eIF4F 
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Per liter:  
20 g of LB Broth base and filled to a total volume of 1 L with deionized H2O. 
Autoclave sterilization for 20 minutes at 15 lb/sq. in. on liquid cycle. 
   
2XYT Broth 
40 g of LB Broth base and filled to a total volume of 1 L with deionized H2O. 
Autoclave sterilization for 20 minutes at 15 lb/sq. in. on liquid cycle. 
 
Terrific Broth (TB) 
(Tartof and Hobbs 1987) 
 
Per liter: 
 To 900 mL of deionized H2O, add: 
 Bacto-tryptone   12 g 
 Bacto-yeast extract  24 g 
 Glycerol   4 mL 
 
Autoclave sterilization for 20 minutes at 15 lb/sq. in. on liquid cycle.  Allow solution to cool 








Per 150 mL: 
50 mM HEPES, pH 7.6    7.5 mL of 1 M 
0.6 M KCL      6.71 g 
20 mM Imidazole     204 mg 
Protease inihibitor cocktail no EDTA* (Roche) 1 Complete tablet (or 5 mini-
Complete tablets) 
deionized H2O      fill to 150 mL 
 
*no EDTA is necessary because EDTA is a chelator of metal ions and would strip Ni from the column. 
 
Elution buffer 
Per 50 mL: 
 
20 mM HEPES, pH 7.6    1.0 mL of 1 M 
100 mM KCL      0.37 g 
250 mM Imidazole     0.85 g 
deionized H2O      fill to 50 mL 
 
Strip buffer 
Per 50 mL: 
80 mM HEPES, pH 7.6    4.0 mL of 1 M 
0.6 M KCL      2.24 g 
100 mM EDTA     1.86 g 
deionized H2O      fill to 50 mL 
 
Charging buffer 
Per 50 mL: 
50 mM NiSO4      0.657 g 
deionized H2O      fill to 50 mL 
 
N’ +0.1 M KCl 
Per liter: 
 
10% glycerol      100 mL 
20 mM HEPES, pH 7.6    20 mL of 1 M 
0.1 M KCL      7.46 g 
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100 mM EDTA     200 µl 0.5 M 
2 mM DTT      1 mL of 2M 
deionized H2O      fill to 1 L 
 
N’ +0.3 M KCl 
Per liter: 
 
10% glycerol      100 mL 
20 mM HEPES, pH 7.6    20 mL of 1 M 
0.1 M KCL      22.38 g 
100 mM EDTA     200 µl 0.5 M 
2 mM DTT      1 mL of 2M 
deionized H2O      fill to 1 L 
 
Western Blot Buffers 
Anode 1 buffer 
Per 250 mL: 
 
300 mM Tris-HCl, pH 10.4    30 mL of 2.5 M 
0.05% SDS      1.25 mL of 10% 
10% methanol      25 mL 
10 mM BME      1 µl 
deionized H2O     fill to 250 mL 
 
Anode 2 buffer 
Per 250 mL: 
 
25 mM Tris-HCl, pH 10.4    2.5 mL of 2.5 M 
0.05% SDS      1.25 mL of 10% 
10% methanol      25 mL 
10 mM BME      1 µl 
deionized H2O     fill to 250 mL 
 
Cathode buffer 
Per 250 mL: 
 
25 mM Tris-HCl, pH 9.4    6.25 mL of 1.0 M 
40 mM α-amino caproic acid    1.2 g 
0.05% SDS      1.25 mL of 10% 
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10% methanol      25 mL 
10 mM BME      1 µl 





























Arabidopsis thaliana eIF4G: Browning Lab cDNA sequence 
         1 tcgactcgat cctttattgt tatttatgac agttttaaga agcccggcaa tgctcaagga 
       61 ggagggcagc ctcgggtgaa tctgccacct gtgaatcatc ctaataatca caacaatggt 
      121 cccaatgctc actctcgctc tcaaggtatg atcgttattc acggagtgcc gcaaagtctt 
      181 taaatttgta taatttcaga ttaatttggt cagtgtgtga gtgatcgttt ggtttagttc 
      241 aatctatctt acactgttag ttacaggaga accgggtgtt ggtggaccaa ccaatccaac 
      301 tgaatcgttc aacagaaaca ccggacctat tccaaaggct ccaacttctc agtctaccgt 
      361 catgagttcc aagatcaatg agacgcccaa cacagctaaa ggtaggtttt tgttgcatcg 
      421 tctatttttt tgtatgcata ctgagctttg aagttgaact aaattcctct gtaattccat 
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      481 aaaggtataa gttttataat gtttattttg ttttgtttag tggcagcctc tggagacgct 
      541 tctcaggcat ttcctctcca gtttgggtca cttggtcctg atttgatggt aatgctgttg 
      601 ttccttcctt tgtttgtttg atttttccat caacacctga ataatcttcc ctgttggttt 
      661 tctaggttcc tgctcgaact acctcagcac ctccgaatat ggatgaccag aaacgtgccc 
      721 aggtggaaca ccttttagta ttatgcatct gccgttactg tgattgttgc ctacataaat 
      781 aattctttct tataggatga tgaatagtct gtgtctcgaa ctttgcttct gacttttaaa 
      841 tgctctatca tttgtcttgt attgcgattt gctggcctga ttgcttgatc tttaactcaa 
      901 attggtttaa agaatatata ctgaaactta agatgtcttt tattcacttt gttctgaact 
      961 tgacctttcg tttatgacac gagcaaacat tgttttgcag atgcagcaat cttctttaag 
     1021 aacggcgtca aatgtgccag cttctgtacc caaaaaagat tcatcaaata agggtgcaga 
     1081 taatcaattg atgaggaaag aggggcacaa tccatcgagt gaaaaagctg atatccaagt 
     1141 cccacatata gcccctccaa gtcaaacgca gaagtctcca attacaaata ttcgcatgcc 
     1201 ttctgtgcag acaccatatc agcatactca ggtccctcac cctgtacatt ttggtgggcc 
     1261 gaatatgcat atgcagcctc ccgtgactgc aacctcgttt cagatgccaa tgccaatggc 
     1321 attatctatg ggaaatactc ctcaaatccc gccgcaggtg ttttatcagg gacatccacc 
     1381 acatccgatg catcatcagg gtatgatgca tcaggctcag ggacatggtt ttgcaactcc 
     1441 aatgggtgct cagattcatc ctcagttagg ccatgtgggt gtgggtttga gccctcagta 
     1501 tccccagcag caaggtggaa aatatggtgg ggcacgcaag accacccctg taaagattac 
     1561 acatcctgac acacacgaag agctgaggct tgatcgacgt ggtgacccgt attcagaagg 
     1621 cgattcaacg gctttaaaac cacattctaa cccacctccc agatcacagc cagtctcatc 
     1681 atttgctcca agaccagtca atttggtgca accctcatat aactccaata ccatgatata 
     1741 tcccccggtt tcggtaccgt taaataatgg tccaatgtca tccgctcagg caccgagata 
     1801 tcattaccca gttattgatg ggtctcagag agtacaactt atcaaccaac ctgctcatac 
     1861 tgctccacag cttatcagac ccgctgctcc tgcacatctt tcctctgatt cgacttcctc 
     1921 tgtgaaagca cgcaatgccc aaaatgtaat gtcatctgct ctacctgtaa atgcgaaggt 
     1981 atcagtgaag ccagctgggg tttctgaaaa gcttggatca ccaaaagaca ggtcacatgg 
     2041 agaagttaac atttctctgt cacaaaagaa cgtggaggca tgttcgttga gctcttccca 
     2101 gcagccgaaa cctagctttg tctctggagt accaaattcg tctgctccgc cagcaaagtc 
     2161 gcctgtggag actgttccgc tagcaaagtc gtctgtggag actgttccgc cagtaaagtc 
     2221 gtctgtggag actgctccag ttacaacgac tgaaatcaga agagcggaaa tggtgagtga 
     2281 gtcgatctca gttgaagatc agacatgtaa ggtggaaccc cctcataatc tgactgaggt 
     2341 atgatactgt gttttgtttt tgggtattat tcattaattc tttttcttat ttgattaaat 
     2401 tattttcttt ttttggctgg ttcactcaga atcgtggaca gactatgcca gactctctgg 
     2461 tctctgatcc tgaaacagca accgttgctg ccaaggaaaa tttatcactc ccagctacca 
     2521 acgggtttag gaagcaactc ctgaaggtgt ctactacatc tgatgctcca acttctgact 
     2581 cagtagatac aagtattgac aaatctacgg aaggttcaag ccatgcctca tcggagattt 
     2641 ctggttcttc accgcaagag aaagacctaa aatgtgataa ccggactgct tctgacaagc 
     2701 tcgatgaaag gtctgtaatt tctgatgcaa aacacgaaac actgtcaggt gtgcttgaga 
     2761 aggcacagaa tgaggtagat ggtgccacag atgtctgtcc tgtctctgaa aaactagctg 
     2821 ttacagatga tacgagctct gaccttccac attctactca tgttctgtct tctactgttc 
     2881 ctcttggaca ttcggaaaca cataaatctg ctgttgaaac aaacacgaga agaaatactt 
     2941 ctacaaaagg aaagaagaag ataaaagaaa tccttcaaaa agcagatgct gcagggacaa 
     3001 cttctgatct ctatatggct tacaaagggc ctgaggaaaa gaaagagagc tcaaatgttg 
     3061 ttcatgatgt ttcgaaccag aacctgttac ctgccatacc tcaggctgtt gaagccattg 
     3121 tggatactga accagtgaaa aatgaaccag aagactggga agatgcagcc gatgtttcta 
     3181 caccaaagct ggaaactgca gataattctg tgaatgcaaa gagaggttcc tcagatgagg 
     3241 tcagcgacaa ctgcatcaat acagaaaaga agtactcccg ggatttcctc ctaaagtttg 
     3301 cagacctgtg tactgctctt cctgagggat ttgacgtttc gcctgatatt gctaatgcct 
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     3361 tgattgttgc atatatgggt gcatcacatc atgaacatga ttcatatcct actcctggaa 
     3421 aggttatgga tcgccaagca agtggtgctc gtttagatcg ccgtcccagc aacgtggctg 
     3481 gtgatgatag atggacgaag aatcagggtt ctcttccagc aggatatggg ggtaacgtag 
     3541 gtttccgacc tggtcaagga ggaaactcgg gagttttaag aaaccctcgt atgcagggac 
     3601 caattatatc tagaccgatg caacctgtgg gtcctatggg aggaatgggt agaaataccc 
     3661 ccgacttaga aaggtggcaa cgtggttcaa atttccaaca aaaaggactt tttccttctc 
     3721 cgcacactcc tatgcaagtg atgcacaaag ccgagagaaa ataccaagtg gggacaattg 
     3781 cagatgaaga acaagcaaaa caaaggcagt taaagagcat cctgaacaag ttgaccccac 
     3841 aaaactttga gaaactgttt gagcaagtta aaagtgtcaa cattgacaac gctgttacac 
     3901 tttctggtgt catttcacag atatttgaca aagccttgat ggagccaaca ttctgtgaga 
     3961 tgtatgcaga tttctgtttt catctctctg gggcgttacc tgattttaat gagaatggtg 
     4021 aaaagattac cttcaaaaga ttgcttctca ataaatgtca ggaagaattc gagagggggg 
     4081 agaaagaaga ggaggaagcc agtagagttg ccgaagaagg tcaagtagaa caaaccgagg 
     4141 aggaaaggga agagaaaaga cttcaggtgc gaaggagaat gcttggtaac atcagactta 
     4201 ttggtgagtt atacaagaaa aggatgttga ctgagaaaat catgcacgca tgcatccaga 
     4261 agttgctcgg gtataatcaa gatccacatg aagagaatat tgaagctctg tgtaaactaa 
     4321 tgagtacgat aggagttatg atcgatcaca acaaagctaa gttccagatg gatggatatt 
     4381 ttgagaaaat gaaaatgcta tcatgcaaac aagaattgtc ttctagggtg aggttcatgt 
     4441 tgatcaatgc catcgatctg agaaagaaca aatggcagga gagaatgaag gtcgaagggc 
     4501 cgaaaaaaat tgaggaagtg cacagagatg ctgcacaaga acgccaaact caagcgaata 
     4561 ggctttcacg tggaccctca atgaattcgt caggaagaag agggcatatg gagtttagta 
     4621 gtcctagggg aggaggagga atgctatcac ctccagctgc ccaaatgggt agttaccatg 
     4681 gaccacctca aggtcgtggc tttagtaatc aggacattcg atttgatgac aggccatctt 
     4741 atgagcctag gatggttcca atgccgcaaa ggtcagtatg tgaggagcct attaccttgg 
     4801 gtccgcaagg tggtcttggt cagggaatgt ctattagaag gcctgcagta gcatcaaaca 
     4861 cttatcagtc tgatgctact caggccggtg gtggagattc taggcgaccg gccggtggtt 
     4921 tgaatggttt tggctcacat agacctgcaa gtcctgttac tcacggacgg tcaagtcctc 
     4981 aagagcgggg aacagcttat gttcataggg aatttgcaag tctgtcgcgt gcttctgatc 
     5041 tgtcaccaga agtttcgtcc gctaggcaag tactacaagg gccatcagct acagtaaaca 
     5101 gtcctcgaga aaatgctttg tctgaagaac agttagagaa tctgtcattg tccgcaatta 
     5161 aggaatatta caggtactat atctctcctt tcttgctggt catttgtttc atttttcgca 
     5221 aagtcatcag atactgccac atttaggaaa ttattctgtg ggaacctgtg taggtataat 
     5281 tggatcaaat tacagttcat tcgtttacag ttagagcgtt tgtttacaac gacagatcat 
     5341 ctgataaagt gtatatttct tgaagtatgt aaattagaat ttgctccaaa caaaacggct 
     5401 taaaaataca tatgagagac tttgttcttt gactttaata gaatctctaa tacaggggta 
     5461 aactctgttt tttttactga ctgtgcgttt tatgtatgat gttagtttct attcgtttac 
     5521 cctctttatt attgataagc actctggtgc gttccaatgt gttcttgtgc agtgcccgag 
     5581 atgagaatga gattggtatg tgcatgaaag atatgaattc accagcttac cacccaacaa 
     5641 tgatttctct ctgggtaact gattcgtttg agagaaaaga caaagaaagg gatctcttag 
     5701 caaagctcct tgtgaacctc gtgaaatctg ctgacaacgc cttaaacgaa gtccagctag 
     5761 tgaaagggta agtaaacaaa gcccataaat cttgaagccc tagtctaatc aaacgtctgt 
     5821 tgcttaaatc ttttactgct ttttttttca caggtttgaa tcggttttga aaaccctgga 
     5881 ggatgcagta aatgatgctc caaaagcagc agagtttctt ggtagaatat ttgggaaaag 
     5941 tgtgacagag aaagtagtga cattgacaga gattggtcgg ttaatccagg aaggaggaga 
     6001 agaaccagga agtctgatag agtttggatt aggcggcgat gttcttggga gtgttttgga 
     6061 gatgataaaa acagaagctg gagaagaaac gttggttgag attcgccgga gctcaggtct 
     6121 gaggattgaa aatttcaaac ctcatgcacc taaccggtct aagatattag agaaatttac 
     6181 ttaggaaaaa aaaatggaac catcttttgg gttcctttct tcttctcttt ttttgtttct 
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     6241 ctcttaaaag tcttttctct tttcaagtgc ttcaaacaaa actaatttgt tataaaggga 
     6301 gtttctctat tttattatat agcaaaaaac ttccaaaatt tctcatttct gtgtttaacc 
     6361 ttttcgtaca tcagttttaa agcacagaga gctcaatgtt cttccaatat cgttattaat 
     6421 aaattttgat taaattcaat caaatcggag ttatattacc acatgaggtt aaagggccat 
     6481 attaaaaagt ctgcacttca tatgagcaac aaggctttta tgtctttatg gttgatttga 
     6541 tggcccatat aagatagttc aaaggcccat attaaaaaat gccctaacat gattcgattc 
     6601 gtatataaag acgcttaatg tgacaagcga acttgctcat tagggtttct catctacgac 
     6661 ggcgtggtgt tcctccttcc tgctctgaaa aatggtgaaa aacctaatcc tttctttttg 
     6721 ttattgttct tgaatctctg taattccata gcaagttatt cgagtatact tccttctgtc 
     6781 tcgttctagc tttcgttttg agatttcaag tttcatagtt gatctgtgga ttctgataga 
     6841 agtctagttt tgtgattttg tcttttgact ctattactct ttttcgatgt ttcacaggcg 
     6901 aagagaacga agaaggttgg aatcgtcggc aaatacggta atgttcctga ctcatctctt 
     6961 attgaatcgc ttaggatgtt aatgctatcg aaaataagga taggatctgc aaatttgcgt 
     7021 agtcttgtag ctcattttaa tggagtatat taacatgtat cgttcatttt tgattacatg 
     7081 ttgtcaatat gtaatggatc tgtctacact ggtttcatat tgcaattcgt tcttcatttt 
     7141 ggggtctaag ttggttatta tatgtattgt gagttctctt cctaacgtat gtatggttat 
     7201 gtgattcagg aacacgttat ggtgcgagta tcaggaagca gattaagaag atggaggtca 
     7261 gccagcacag caagtacttc tgtgagttct gtggcaaggt atgaaagaga ttaacattca 
     7321 gttactgttt tcatttctaa atctcttttg gttttggatt attgtggtaa ctgtggtttg 
     7381 atcaaaatga ttgcagtacg gagtgaagcg aaaggctgtt ggtatctggg gttgcaagga 
     7441 ttgtggcaag gtcaaggcag gtggtgctta cacaatgaag taagtgattt ctgagttata 
     7501 tttgtattag ctttgtgttg gttatcaatc aatgatttgt tttctgatga aattgttttc 
     7561 gtttgtgaat tgcagcaccg ccagtgcggt cactgttaga agcacgatca gaaggttgag 
     7621 ggagcagatc gagggttaaa agtctgctgg ctttttatat ttggtttcct tgttttgaca 
     7681 atttaagttt tgcaaactct atgcttgtga ttttgaatca agacttatac attgagcagt 
     7741 ttaagcaggt ttttattttt tgttgagtta attttcaaag tttcattacc aatagttcta 
     7801 gctatataac ctaaagttag gcttgaggtt ttgaatgttt gatcctattc aacacctaat 
     7861 tataaatcct tgaatcctga tctaatgtga tgtttcttat actttatttt gatcagcact 
     7921 tctttaaccc tataacttgg taacagtatt cgcacgagtc tttacagatc aaaattttta 
     7981 gagtttgatg tgtgttttca aagtgcttta ctagaaatcc ttacgataat acaatctata 
     8041 actgagtgta ctaagtttaa ttacacaaaa gtcggtgaat aaacaaatac taacgttact 
     8101 ggtttttatg tctggcaatg atctcttata aaatctatat attgacttgt ttatatgctt 
     8161 ttgtgtcgta atcatcctaa gatattggtc ccttgagtgt attttaatgg ccatacatgt 
     8221 ctcattatga tctttgatga aattgattga tctaagttat acttcagttg aaatttatga 
     8281 gttttacatg aaattagaaa aacgaataat aatccaacag ttcaaaacaa aatccaacta 
     8341 actggggaaa atcttttcgg agacaacaac aagacccaag tgtgtcgttc ttttccccca 
     8401 atgagccagg ctgttgcact tctaagtttt cttggaactt catgagattc tttcaagatt 
     8461 ctatctttca acttcagctc tcatcctcta acccaatggt tgatgtatgc tccagtcacc 
     8521 gcagctatcg tttcagttgc tcatccggat gcaattacag agccactaaa tgtatcacca 
     8581 ttgagaatgc agagcactag tatcatggtt tgtgtacctt gaagccaaag atttttggga 
     8641 catagctttg agtaggcttc tgcggcttta agttcccgta agtcatcaag aacaagtgag 
     8701 ggaatgtggt tccaaagtac gctccatcaa tatctgcaca agtcatttaa ggaaaacgct 
     8761 aagatacaat gacactcaag atcagagtgt ctcaactgaa gcaaaatcag acctaagctt 
     8821 tcactgaaat attgaaatgg caaagccaaa attatggatt atggaacaga gaaaaaggat 
     8881 actgccttgg aatttagatc gcggggtaag atatatcctc gcatttaggg cagtatatct 
     8941 tcacagtact cgatctcggg atatcggatt gtccaactgg aagacaagac tgaccgcaac 
     9001 agaaaactct cgggcatctc ccgaaatcac agttcttgta cttctcagtc tacagagatc 
     9061 aataaacaag agacgtcgtt aatcaaataa cgaagctaaa agcaccaaaa cataaacaaa 
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     9121 agagtagaga gattctctaa ctaaccattg cagccattcc tttagtagtc aaaatgtaac 
     9181 gaacatgaat aagaccatat agcatctcag cagctgattc caccatttca tgctgttcat 
     9241 cagtaaacat ctcacctaaa catagataca agatttcaga ccaaacttta ctagctcctt 
     9301 attaacaaaa aaagaaagaa gaagaagaag agagatgact tactgttgga agcatcaaca 
     9361 tctaaaatga gatcaagtgc ataatcatag taagggactt gaccacttaa accacaaaga 
     9421 ttgaaatcat cttgaatata atcttcatcg acttcacaga agaaatcatt ccctctcaaa 
     9481 ttacaaaacc aagagatcca cgacgtatca tcaccctccg atccactcac atcagaccat 
     9541 tcactatcag tttccgattc cactgcaaca ccaaaaaaaa aaaatcatca gaaagaaagc 
     9601 aattaaccaa caaaaagact cacagatgtg aaaaagagag gaacaaacca tcaggaagct 
     9661 gagttttagt agatgtgaag gaaaagggat ctttgtcttt agaagagaaa accctagatg 
     9721 tggtggtgga agttgaagat ttctctagtt tcttattgag tgcatcgttg attcgtttcc 
     9781 gatcaatagc tccaccgagg atctctgatc tcgatgaccc accaccacct cctccactac 
     9841 gttccttgta cataattcga ttccttctcc aaaaagacaa gaaatttgga gattagattc 
     9901 tcgaaagtgt cagactttct gagaagcttg agagagaaag gaaattagag agacggagaa 
     9961 atctagggtt ttcttctttt taattttaat tttttttaaa aaattatata taattttggt 
    10021 aacagagtgg aggacaggac ataggcgatg taaagatggt ctctctttct cctctcaact 
    10081 gttttgtttt tttttgcttt ccagtttttg ttctttctat tttacaatgg gcttctataa 
    10141 ttgggccttg tgttagctaa agtcagttta gtctcattgc ttgcttccat cagaaacgac 
    10201 caaaacagat gggccacagc ccacataaga tgaaatccat aaatcgtgaa caaacatgac 
    10261 aaccaacaag attacgattt ttggaattag agtacatata catgttggaa cttggaagat 
    10321 gcattggtca acggagctag acctgacaaa ggtcttcgga taataataat atcgtaaaca 
    10381 ttaaggaaac tttttaattt taaaaaatcg gacatgaaga gcacgaattg aactctatac 
    10441 aaaatctaga gttgaatcgt gtttcagaaa ctgaagtaca cgagcttgtg gtggcgtggt 
    10501 gcacgactct gcataaaact cattatatta tctattcaaa atctaagcat ttgtttcaga 
    10561 caacacaagt ttcattttta aaagatctcg acttacgaca aaaaaaaaaa aaaaagatct 
    10621 cgactttttt tgttagttaa atactacaat agtttgagaa atattttgta tttattttat 
    10681 tttttttagt ttgagaaata ttttgtattt cttcgtttgt gttcaagtaa agtttgtgat 
    10741 ccacgtttat atacaaaatt gatagataaa aattggactg gcatatcatg taatatacac 
    10801 acccaaacat aatttttggg atctagaaac atttgcttgc agaacggagc ctttgtcgga 
    10861 gaaagtagtc atgcctcgtt acaacgactt ttgacaattt cccaaaagtt ttatagaagt 
    10921 tgtaaattta atactagtag ttgtatattg aaattttatt tttgcattaa acggtaagga 








DNA restriction digest  
1. Incubate plasmid DNA, restriction enzymes and appropriate buffers at 37ºC for 1 hour.  
2. Add 1 µl of shrimp alkaline phosphatase (SAP) to the vector restriction digest.   
3. Restriction digests are allowed to continue for an additional 30 minutes at 37ºC.   
 
Ethanol precipitation of DNA 
1. Cut desired gel band out and place in a 1 mL eppendorf tube. 
2. Add 0.1X (X being the volume of the DNA sample) 3M NaOAc and 2X cold absolute 
ethanol.   
3. Contents are mixed and pulsed in the table-top centrifuge and liquid is removed from the 
pellet.   
4. 200 µl of 70% cold ethanol is added and the sample is spun down.   
5. Once again, the liquid is taken off.  The sample is spun down again and any remaining 
liquid is removed.   
6. Then, the open tube is placed in a 37ºC incubator to dry for 10 minutes.   
7. The pellet is resuspended in 5.5 µl of de-ionized water. 
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Ligation of DNA 
1. Combine 3 µl 5X ligase buffer, 1 µl T4 DNA ligase, 5.5 µl DNA of gene insert, 3 µl DNA 
of vector and 2.5 µl de-ionized water.   
2. This 15 µl ligation reaction is incubated at 4ºC overnight.   
 
Ligation of DNA 
1. 20 µl of competent cells are thawed on ice and 1 µl of ligation DNA is added.   
2. This mixture is incubated on ice for 30 minutes. 
3. Heat shocked for 1 minute in a 44ºC water bath.   
4. The mixture is then placed back on ice for 2 minutes.   
5. 1 mL of LB is added to the mixture and is incubated at 37ºC, shaking, for 1 hour.   
6. This mixture is then plated on an appropriate antibiotic LB plate and incubated at 37ºC 
overnight.   
 
Screening transformed colonies for the correct DNA insert 
1. Perform plasmid DNA prep by starting 5 mL LB cultures, containing 100 µg/mL of the 
appropriate antibiotic, for the colonies.   
2. These cultures are incubated at 37ºC shaking overnight.   
3. Also, a patch plate is made of all colonies tested on an LB antibiotic plate, and incubated 
at 37ºC overnight.   
4. The next day, the 5 mL cultures are used to perform a Mini-prep according to the 
manufacturer’s instructions (QIAgen) and eluted with 40 µl de-ionized water.   
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5. Each of the plasmid DNA preps were tested by a restriction digest to determine whether 
the DNA was successfully inserted into the vector suing appropriate restriction enzymes 
according to the procedure above for restriction digest. 
6. The completed restriction digest is run on a DNA agarose gel. 
7. Check for correctly sized DNA fragments. 
 
Basic protein expression procedure 
1. Using a single colony, 250 mL LB cultures containing 100 µg/mL appropriate antibiotic 
are started at 37ºC shaking overnight.   
2. The next day, the 250 mL culture is poured into a 1 L LB flask containing the antibiotic, 
and is left shaking at 37ºC until OD600 reaches around 0.4-0.6 absorbance.   
3. At this OD600, most of the bacteria are in log phase, and are in a good state to express 
proteins when induced by IPTG, which acts to activate the lac operon that controls the 
recombinant gene.   
4. The induction phase is left for 3 hours, shaking, at a temperature of 30ºC. 
5. The cells are harvested by being centrifuged in the JA-10 rotor at 5.5K rpm at 4ºC for 15 
minutes.   
6. The bacterial pellet is transformed into a 50 mL test tube and stored at -80ºC.   
 
12.5% SDS-page gel 
1. Clamp a 12.5% SDS-page gel in the upper chamber of a gel apparatus and seal around the 
gel using 1% melted agarose. 
2. Place the gel comb in between the two plates of the gel and pour stacking gel into this 
opening. 
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3. Let the stacking gel polymerize for about 20 minutes, or until solid. 
4. Pour 1X running buffer into the upper and lower chamber. 
5. Remove the gel comb. 
6.  Load protein samples and molecular weight marker into the formed wells. 
7. Finish assembling the gel apparatus and electrophorese at 30 mA for 45-60 minutes. 
8. Remove the gel and stain in Coomassie Brilliant Blue stain for 10 minutes. 
9. Place gel in destain solution for about 1-2 hours. 
 
Western blot 
1. Run a 12.5% SDS-page gel according to procedure above. 
2. In the membrane blotting apparatus, two pieces of blotting membrane, cut to the size of 
the gel, wet with Anode 1 buffer (see Appendix A), are arranged.   
3. Then, two more pieces, wet with Anode 2 buffer (see Appendix A), is laid on top.   
4. Then, the PVDF membrane is first wet with methanol and then Anode 2 buffer, is placed 
on top of the blotting membrane.   
5. The gel is also wet with Anode 2 buffer and stacked on.   
6. Two more pieces of membrane are wet with Cathode buffer (see Appendix A) and laid 
on the very top.   
7. The blotting apparatus is run at 100 mAmps for 1.5 hours.   
8. The PVDF membrane is placed protein-side facing up in a clean container with 5% 
milk/HNAT solution either shaking at room temperature for 2 hours, or at 4ºC overnight.   
9. The solution is poured off the membrane and 5% milk/HNAT containing 1:10,000 
concentration of the primary and secondary antibody, in our case, anti-His C-terminus-HRP 
antibody (Invitrogen), is added and is left shaking at room temperature for at least 1 hour.   
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10. This solution is poured off and 3-5 rinses of 5% milk/HNAT for 5 minutes each are 
done, with the last few washes performed using HNAT only.   
11. The PVDF membrane is developed using equal parts of the two reagents provided in the 
chemiluminescence kit (Pierce).   
12. This solution is left on the membrane to react for 10 minutes.   
13. Using film, luminescence can be picked up on the membrane, indicating a protein that 
bound the anti-His tag antibody successfully. 
 
Preparation and Care of the Ni-NTA column 
1. After every use, the Ni-NTA column is stripped with 3X the column volume of strip 
buffer (see Appendix A)  
2. The column is stored in binding buffer with 30% ethanol.   
3. The day before the next use, wash with 3X the column volume with charging buffer (see 
Appendix A). 
 
